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A B B R E V I A T I O N S 
ВАНА = Bone Anchored Hearing Aid 
ACHA = Air Conduction Hearing Aid 
CBHA - Conventional Bone Conduction Hearing Aid 
CHA = Conventional Hearing Aid 
PTAbc = Average Bone Conduction Threshold at 0,5, 1 and 2 kHz 
PTAac = Average Air Conduction Threshold at 0,5, 1 and 2 kHz 
ВС group = group of patients previously fitted with a conventional bone 
conduction hearing aid 
AC group = group of patients previously fitted with an air conduction 
hearing aid 
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pbc 
dB HL 
dB(A) 
dB SPL 
kHz 
ENT 
UHN 
= Performance-Intensity 
= Phonetically balanced 
= Maximum Phoneme Score 
= Speech-to-Noise 
= Transcutaneous Bone Conduction 
= Percutaneous Bone Conduction 
= deciBell Hearing Level 
= weighted decibels (according to IEC 179) 
= deciBell Sound Pressure Level 
= kiloHerz 
= Ear, Nose and Throat 
= University Hospital Niimegen 
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Introduction 
INTRODUCTION 
Sensorineural or inner ear hearing loss is the most common form of hearing 
impairment In most cases, the only treatment is to fit unilateral or bilateral air 
conduction hearing aids These devices (the behind-the-ear or in-the-ear hearing 
aids) introduce the amplified sound in the auditory canal Conductive hearing 
loss is a second, less common type of hearing loss and is the result of middle ear 
abnormalities Patients with a conductive hearing loss may be suitable for surgi-
cal reconstruction, if not they may be fitted with an air conduction hearing aid 
Bilateral deformities of the pinna and aural canal often make it impossible to fit 
such a hearing aid and recurrent or persistent otitis media or externa may also 
be unsuitable because the hearing aid blocks the auditory canal In such cases, a 
bone conduction hearing aid is fitted 
The transducer of a conventional bone conduction hearing aid is firmly pressed 
against the vault of the skull Sound vibrations are transmitted to the inner ear 
via the skull where they can be perceived (Figure 1 ) Three types of convention-
al bone conduction hearing aid are available (Photo 1 ) hearing spectacles with 
the transducers mounted in the frame, a headband with the transducer on one 
side and the behind-the-ear hearing aid on the other, and a headband with the 
transducer connected to a body-level hearing aid The latter configuration is the 
most powerful but it is also the least attractive cosmetically It is only fitted if 
the pinna is deformed or absent, or if there is severe sensorineural hearing loss, 
or if easy handling is necessary for reasons of age or infirmity 
THE PHYSIOLOGY OF BONE CONDUCTION 
The principle of bone conduction has been known for centuries In the 17th cen-
tury this phenomenon was applied using a hearing aid for patients with impaired 
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Figure 1. Diagram of sound conduction to the cotillea νια the auditory canal 
with an air conduction hearing aid f ACH A J and via the skull with a 
conventional heme conduction hearing aid (CBHA). Fremi Carh.son 
(1990)' 
hearing (see 1.3- History of the conventional bone conduction hearing aid). 
Since the early part of the 19th century, bone conduction has been used diagnos-
lically to differentiate between conductive hearing loss and sensorineural hearing 
loss. After the initial practical interest, more attention was paid to the physiology 
of bone conduction. Most of the currently accepted concepts of bone conduction 
have evolved in the present century . 2 , 4 S 6 7 8 
Von Békésy demonstrated that sound signals conducted to the cochlea by air or 
bone conduction stimulate the cochlear receptors in an identical manner. He 
studied the cancelling of sound signals (pure tones) during simultaneous stimula-
it) 
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Photo 1. The conventional cone conduction hearing aids 
tion by air and bone conduction.3 Many mechanisms have been proposed by 
various investigators to explain how the basilar membrane is deflected during 
bone conduction. Compression and inertia are the most commonly accepted 
concepts as modes of stimulation. 
The bone-compression concept 
Reitjö was the first to postulate that compression of the inner ear made a contribu-
tion to sound perception through bone conduction (1914).9 This concept became 
generally recognised after the experiments performed by Herzog and Krainz 
(1926).2 Vibratory energy which reaches the cochlea causes alternate compression 
and expansion of the cochlear shell. The cochlear fluid has to yield under the influ-
ence of the opposing movements because it cannot be compressed. Compression of 
the cochlea would not produce inner ear fluid displacement if the cochlear scalae 
were of equal size and shape. However, the total surface of the contracting walls on 
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the vestibular side is larger than on the tympanic side of the basilar membrane, with 
a ratio of approximately 3 2'° Consequently, more fluid is displaced in the scala 
vestibuh than in the scala tympani, which forces the cochlear partition downwards 
Secondly, the displacement of the fluid is enhanced by the presence of the semicircu­
lar canals and vestibule in the region of the stapes Compression of these compart­
ments forces fluid into the scala vestibuh which forces the basilar membrane down 
In addition, volume changes in the cochlear spaces could be the result of the fact 
that the oval window is known to be less compliant than the round window 
According to Kinkae (1960) the compliance ratio is 1 20 " Therefore, the round 
window would yield more than the oval window under pressure This amplifies the 
basilar membrane movements The perception of sounds by compressional bone 
conduction has its largest contribution at high frequenciesλ 
The inertia bone conduction concept 
The malleus and incus are loosily coupled to the skull Inertia of these two 
major ossicles means that vibration of the skull will set up a vibration of the 
ossicles relative to the skull According to Moller (1963) the malleus and the incus 
vibrate together as a unit and in phase without movement in the incudo-malleal 
joint r The motion of this unit is like that of a pendulum or piston which is free 
to rotate or vibrate around an axis held in a support while the support is also 
vibrating The relative motions between the ossicles and the skull set up stapedi­
al displacement which leads to cochlear stimulation in the same manner as in air 
conduction 
Von Bekesy (1932) and Barany (1938) were the first to theorize on the concept 
of ossicular inertia on the basis of experiments on human subjects1 4 It was 
found that this middle ear component is modified by the impedance of the tym­
panic membrane, the air enclosed within the middle ear and the air contained in 
the auditory canal In experiments, loading the tympanic membrane or the 
12 
Introduction 
stapes with small weights shifted the centre of gravity of the ossicular chain and 
modified the middle ear component in a predictable manner The inertia concept 
was also applied to the inner ear fluid and argued to be equally important as the 
ossicular inertia " 
The two concepts of bone conduction described above, the compression concept 
and the inertia concept, represented two schools of thought which were often 
viewed as incompatible A significant contribution to the theory of bone conduc-
tion was made by Tondorf (1966) who stressed that the phenomenon of bone 
conduction cannot be explained by a single mechanism '4 He identified and 
quantitatively assessed eight factors and several subfactors which all contribute 
in various ways to the stimulation of the cochlea Two major mechanisms have 
been described above The remaining major mechanism concerns the radiation 
of vibrations into the auditory canal by the vibrating bony and cartilaginous 
walls of the auditory canal which reach the tympanic membrane Closing or 
opening the auditory canal will increase or decrease this effect. Any impairment 
in the middle ear will eliminate or reduce the transmission of sound developed in 
the auditory canal 
HISTORY OF CONVENTIONAL BONE CONDUCTION 
HEARING AIDS 
The first application of the phenomenon of bone conduction to aid patients with 
an impaired hearing emerged in the 17th century The first bone conduction 
hearing aids consisted of a rod of glass, steel, copper, silver or wood which was 
used to conduct sound A good example is the Fonifero developed by Professor 
Paladino at the University of Naples in 1876 One end of the metal rod was 
placed against the larynx of the speaker and the other end against the teeth or 
mastoid process of the listener (Figure 2) 
13 
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Figure 2. The Fomjeio imented b} Professai Paladino 
A tod, В speakei's end С listener's end Fiom Beiger ( 1976)'* 
Towards the end of the 19th century, more sophisticated bone conduction 
devices were developed They consisted of a thin diaphragm to pick up sound 
which was subsequently conducted to the user's teeth (the Dentaphone) These 
devices were often constructed to resemble a fan, available in a folding version 
(the Audiphone) or with ornamental features to disguise the hearing aid Despite 
the fact that these bone conduction hearing devices were inconvenient to wear 
and had poor reproductive qualities, they were popular until the invention of the 
carbon-electric hearing aid in the early 1900s '5 The new electric bone conduction 
14 
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hearing aid consisted of an eleclro-magnetic vibrator pressed against the 
mastoid process by a steel spring or headband positioned over the head and was 
connected to a body-level power processor. The aesthetic appearance of the bone 
conduction hearing aid was improved with the invention of hearing spectacles as 
its components are mounted in the arms of the spectacles. Initially, the 
microphone and amplifier had to be mounted on the opposite side from the 
transducer, but later the possibility arose to mount transducers bilaterally. 
Owing to advances in the miniaturisation of individual components and in 
general technology, it became a simple task to design hearing spectacles with an 
attractive frame. To this day, these conventional electric bone conduction 
hearing aids are still fitted successfully. 
THE BONE A N C H O R E D HEARING AID 
The transducer of a conventional bone conduction hearing aid must be pressed 
against the mastoid using a tight-fitting spectacle frame or headband to achieve 
a good perception via bone conduction (Photos 1 and 2). The pressure required 
sometimes causes complaints such as persistent skin irritation, pressure sores and 
headaches (Photo 3). If to avoid these problems, the patient does not press the 
transducer firmly enough against the mastoid, insufficient sound transmission 
may occur. For patients with major conductive hearing loss who also have a 
major sensorineural component the inability of the conventional bone 
conduction hearing aid to produce sufficient sound levels may pose a problem. 
In Göteborg, a new type of bone conduction hearing aid, the 'bone anchored 
hearing aid' (BAHA) was developed which has been commercially available since 
1987 (Photo 4). The BAHA system transmits sound directly to the skull without 
interference from intermediate tissue.16 The system comprises of a titanium 
fixture anchored into the skull, a titanium abutment fixed to it which penetrates 
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Photo 2. A patient with hearing spectacles 
the skin and a transducer which is connected to the protruding part (Figure 3). 
There is no tissue to impede the transmission of sound and the transducer does 
not press against the skin. 
At the Ear, Nose and Throat Department of the University Hospital Nijmegen 
(UHN) the first implantations of percutaneous titanium implants for the BAHA 
were performed in June 1988. Financial support for the rehabilitation of the first 
10 patients was provided by the University Hospital Nijmegen (Committee for 
New Activities). The first results published, of patients aided with the BAHA in 
Göteborg161718 and at the UHN,19 were clinically and audiologically favourable. 
16 
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Photo 3. Skin irritation as a result of pressure of the transducer 
Therefore, in 1989 the UHN (ENT Department) filed a request to conduct a 
developmental research project to the Committee for Developmental Medicine of 
the Ziekenfondsraad. The request was honoured by the Minister of Education 
and Science and the Secretary of Welfare, Health and Cultural Affairs. 
For the sake of completeness, two other new types of bone conduction hearing 
aid should also be mentioned. The Xomed system is a partially implanted bone 
conduction hearing aid, which consists of a magnet implanted in the temporal 
bone and an external inductive coil positioned above it, creating a transcuta-
neous coupling.2021 The Xomed system can be fitted in patients with conductive 
17 
Chapter 1 
Figure 3. Diagram of the BAH Λ tonnet led to the skull 
(I) skull (2) skin and subcutaneous tissue (3) titanium fixtuie, 
(4) titanium abutment (5) plastit tap, (6) tonneclmg screw, (7) 
plastic insert (8) transducer HC200 
or mixed hearing loss with an average bone conduction threshold at 0 5, 1 and 2 
kHz (PTAbc) of up to 25 dB HL The latest bone conduction hearing aid is the 
'Audiodent', developed by a team of technicians, audiologists and dentists in 
Nice, France A tiny transducer is fixed to one of the posterior molar teeth in 
the upper jaw A body-level device picks up sound and transmits it via a wireless 
transmitter to the transducer, causing it to vibrate This hearing aid is not 
expected to become commercially available until at least 1994 
18 
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AIMS OF THE RESEARCH PROJECT 
When the first patient was implanted for the BAHA at the ENT Department of 
the UHN in 1988, more than 150 patients had been fitted with a BAHA in 
Goteborg Clinical results with percutaneous titanium implants in the temporal 
bone"11T4,s and audiological results with the BAHA had been published by the 
Goteborg group,1617 yet not more than 24 patients were evaluated audiologically 
in any of these Swedish studies The general aim of the developmental medical 
research project BAHA at the UHN was 
to evaluate the applicability and efficacy of a hearing aid anchored to the 
skull by means of percutaneous titanium implant 
Patient selection 
The target group consisted of hearing-impaired patients with conductive or 
mixed hearing loss for whom a conventional bone conduction hearing aid has 
proved to be inadequate and a behind-the-ear or in-the-ear hearing aid impossi-
ble to fit The patients were selected according to a protocol with obligatory 
inclusion and exclusion criteria The results ot otological evaluation had to show 
that microsurgical treatment would not hold out prospects for maintaining a dry 
ear, thus proving that audiological rehabilitation could not take place with an 
air conduction hearing aid Although elective microsurgical treatment is an 
option for some patients with unilateral hearing, the risk of causing deafness in 
the only ear that can hear is generally considered to be unacceptable Chapters 4 
and 5 contain full details of the selection criteria employed for patient selection 
at the UHN In our request to carry out this developmental medical research 
project the inclusion criteria were described as follows 
19 
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1 Conductive or mixed hearing loss in the best ear, with a maximum 
average sensorineural hearing loss component of 45 dB HL at the 
frequencies 0 5, 1 and 2 kHz During the study period, the 'super-bass' 
BAH A HC220 became commercially available which has a transducer 
with a higher output than the standard BAHA HC200 Therefore the 
inclusion criteria were adapted slightly so that patients with an average 
sensorineural hearing loss of up to 65 dB HL could be included '7 A 
proportion of these patients could no longer be rehabilitated adequately 
with a hearing aid owing to the extent of their sensorineural hearing loss, 
not even with the best conventional bone conduction hearing aid The 
Committee for Developmental Medicine of the Ziekenfonds approved this 
change in the protocol 
2 Previous fitting of a behind-the-ear or an in-the-ear (air conduction) 
hearing aid was unsuccessful owing to the absence of an auditory canal or 
persistent otorrhoea Other reasons for unsuccessful fitting were uncon-
trollable feedback problems or an untreatable allergic reaction to the 
earmould 
3 Previous fitting with a conventional bone conduction hearing aid was 
unsuccessful One of the problems encountered included variable speech 
recognition owing to the transducer slipping or variation in pressure of 
the transducer against the temporal bone Most frequently local pressure 
pain, skin irritation, headaches led to rejection of the conventional bone 
conduction hearing aid In some patients with facial deformity and 
frequently in young people, hearing spectacles or a headband gave rise to 
serious cosmetic objections 
20 
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4. Otological review led to the conclusion that microsurgical treatment could 
not offer a reasonable chance of achieving a dry ear. 
Any of the following aspects were considered to be sufficient reason to exclude a 
patient from treatment with a BAHA: 
1. Age younger than 10 years. 
2. Pure sensorineural hearing loss, because it is not yet certain whether 
BAHA a bone conduction hearing aid will be of benefit to these patients. 
3. A conventional hearing aid (air or bone conduction hearing aid) provides 
satisfactory results. 
4. Mixed hearing loss with an average sensorineural hearing loss of greater 
than 65 dB HL at the frequencies 0.5, 1 and 2 kHz. 
5. Lack of personal motivation or acceptation problems. 
F O R M U L A T I O N OF THE GENERAL AIM OF THE 
R E S E A R C H P R O J E C T 
The general aim of the project can be separated into a number of specific ques-
tions. 
1. Do the titanium implants become successfully anchored in the temporal 
bone? An evaluation must be made of whether the high success rate of 
anchorage of the implant achieved in Göteborg (more than 95%) is repro-
ducible. For this purpose, it is necessary to calculate a success rate over a 
21 
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follow-up period of a specific length and to compare the outcome to the 
results reported in the literature The success rate obtained with a one-
stage implantation (1 e in which the fixture is inserted into the temporal 
bone and the abutment is connected to it in a single operation) should be 
compared to that obtained with the generally applied two-stage procedure 
(first stage, insertion of the fixture, second stage, establishment of the per-
cutaneous coupling) 
2 How often and to what extent do soft tissue reactions occur around the 
implant9 Once the percentage of implants which remain reaction-free has 
been established, the outcome can be compared to the results published in 
the literature Attention should be paid to the possibility of an increase in 
the number of skin reactions against time, a difference in the occurrence 
of skin reactions between one-stage and two-stage surgical procedures and 
a relationship between the occurrence of skin reactions and certain circum-
stances 
3 What are the audiological results with the BAHA9 
The first question is whether in audiological terms the BAHA is a good 
alternative for the conventional bone conduction hearing aid A definite 
answer can be obtained by means of psycho-acoustic tests in which the 
BAHA is compared to a conventional bone conduction hearing aid on the 
basis of observations of threshold variation in a free-field set-up and 
differences in speech recognition scores in quiet and in noise An evaluation 
must be made as to whether the BAHA is suitable for patients whose 
level of sensorineural hearing loss is too high for a conventional bone con-
duction hearing aid Interesting in this respect is a possible relationship 
between the sensorineural hearing thresholds and the gain in speech 
recognition in comparison with a conventional hearing aid Similar ques-
tions can be raised with regard to the air conduction hearing aid It can 
22 
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also be questioned whether the results with the individually adapted hear-
ing aids correspond with those of standard hearing aids in other words 
whether possible improvements can be attributed to the difference in the 
hearing aids themselves or to patient-related factors 
By evaluating the audiological results with the BAHA in the present study 
group it may be possible to establish the upper level at which a patient 
with sensorineural hearing loss can still be rehabilitated successfully with a 
BAHA The results may also point out other factors which could be 
usefull as an indicator for a successful fitting of a BAHA, possibly the 
thickness of the skin at the mastoid in former users of a conventional 
bone conduction hearing aid 
What are the subjective results with the BAHA9 
Studying the patients' own experience with the BAHA regarding, for 
example, speech recognition, in addition to the above-mentioned audio-
logical tests, is necessary to obtain a complete picture of the patients' 
performance with the BAHA Do the subjective and audiological findings 
correspond9 Which improvements and which deteriorations are of most 
importance to the patient and how does the patient get on with the 
percutaneous implant9 To carry out a worthwhile comparison, it is neces-
sary to separate the results according to the type of hearing aid previously 
used by the patients 
T H E S T U D Y P R O T O C O L 
Detailed descriptions of the various facets of the study protocol are given in 
Chapters 2 to 7 Below, the study protocol is shown in integral form It can be 
divided into several phases selection, surgical treatment methods, preoperative 
23 
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and postoperative tests and evaluation of the results 
Phase la Selection on the basis of the above-mentioned selection criteria 
1 Intake consultation 
* anamnesis previous history, motivation 
* patient education by means of a Dutch brochure (approved by the 
medical ethics committee ot the UHN) and informative diagrams 
operation and hospitalization, care ol the implant, BAHA HC200 
or BAHA HC220 with body-level hearing aid, personal financial 
contribution, health insurance 
* through improvisation, the patient can become acquainted with the 
sound reproduction of the BAHA by pressing a so-called 'dummy 
implant' to which a BAHA is connected against his or her skull In 
this way an additional important indication can be obtained of the 
best side for the percutaneous titanium implant and whether in 
subjective terms, a standard BAHA HC200 will provide sufficient 
sound amplification 
2 Evaluation of the otological status using microscope, tuning fork tests, 
pure lone audiogram, speech audiogram 
3 Evaluation of the adequacy of the conventional hearing aid and where 
possible, optimahzation 
Phase lb Subjective evaluation ol the conventional hearing aid using a 
questionnaire 
24 
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Photo 4. The BAHA HC220 (left) and the ВАНА HC200 (right) 
Phase 2: First surgical stage 
Implantation of the titanium fixture in the skull under the skin be­
hind the auricle. The procedure can be performed under general or 
local anaesthesia. For patients with long travelling distances to the 
UHN and those who have a general anaesthetic, the period of 
hospitalization is generally 3 days. The patients undergo monthly 
check-ups of the implantation site at the out patients clinic. 
Phase 3: Second surgical stage 
Three to four months after implantation of the titanium fixture, a 
round free skin graft is obtained with a diameter of 10-15 mm. The 
skin and the subcutaneous tissue above the titanium fixture and the 
subcutaneous tissue around this circular incision are removed. The 
skin graft is punctured (hole diameter 2-3 mm) and placed over the 
25 
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Photo 5. The percutaneous titanium implant 
fixture; the abutment is attached and protrudes through the skin 
graft. The skin graft is sutured into place. The device is wrapped in 
gauze covered in antibiotic cream to adapt the skin graft to the 
underlying bone and to promote healing. The postoperative healing 
phase takes approximately one month. During this month the 
patient has weekly check-ups at the out patients clinic (Photo 5). 
In the light of the favourable experience in Goteborg with combining these two 
stages into one procedure,26 we also started to apply the one-stage technique half 
way through the course of the developmental medical research project. 
26 
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Photo 6. The BAHA coupled to the implant 
Phase 4: Coupling the ВАНА to the percutaneous titanium fixture, four to 
six weeks after surgery (Photo 6). 
Phase 5a: Check-ups of the percutaneous implant every four months. 
Evaluation included assessment of: 
* the anchorage of the fixture in the skull 
* adequate fixation of the percutaneous abutment to the fixture 
27 
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* skin reactions 
* unfavourable circumstances, such as a thick skin around the 
implant site, skin disease 
Phase 5b: Audiological evaluation of the patient using the BAHA after at 
least 4 weeks of successful use. Comparison of the results to those 
obtained with the previous conventional hearing aid. 
* transcutaneous and percutaneous pure tone bone conduction 
thresholds 
* free-field hearing thresholds 
* free-field speech audiogram 
* speech recognition in noise test according to the Plomp & Mimpen 
method27 
Phase 5c: Subjective evaluation of the performance of the BAHA using a 
questionnaire. 
* questionnaire filled out after at least 5 months of experience with 
the BAHA 
Phase 5d: Comparison of the audiological and subjective results between the 
previous conventional hearing aid and the BAHA. 
C O M P O S I T I O N AND A R R A N G E M E N T OF THE T H E S I S 
In the period from 1988 to the end of 1992, more than 65 patients were fitted 
with a BAHA. This thesis presents the clinical, audiological and subjective 
28 
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evaluation of these patients up to the beginning of 1993. During the above-
mentioned period other centres in The Netherlands also started to apply this new 
treatment technique: Diaconessenhuis & Audiological Centre Eindhoven in 1989, 
University Hospital Rotterdam in 1990 and the University Hospital Groningen 
in 1992 (see Appendix 111). Collaboration with the centres in Eindhoven and 
Rotterdam has resulted in the presentation of the results from multiple centres 
in Chapters 2, 4 and 5 of this thesis. The results of the clinical evaluation of the 
one and two-stage implantation techniques (phase 5a of study protocol) are 
presented in Chapters 2 and 3. The audiological results obtained for the BAHA 
HC200 and the BAHA HC220 in comparison with the previous conventional 
hearing aids (phases la and 5b) are presented in Chapters 4 and 5. Chapter 6 
describes the results of the measurements of the skin thickness over the mastoid 
and the shifts in bone conduction thresholds caused by the use of the percuta­
neous connection. The subjective results obtained (phases lb and 5c) are 
presented in Chapter 7. 
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I N T R O D U C T I O N 
ΙΓ a hearing aid is required and partial or complete blockage of the auditory 
canal by a conventional air conduction hearing aid is not tolerated, the possibili­
ty of a bone conduction hearing aid remains A conventional bone conduction 
hearing aid consists of an amplifier and a transducer attached to a headband or 
a spectacle frame that presses the transducer against the vault of the skull In 
1985, a new type of bone conduction hearing aid was introduced, the bone 
anchored hearing aid (BAHA), which is coupled to a percutaneous implant 
anchored to the skull ' The system became available commercially in 1987 and 
was first used in The Netherlands in 1988 The present study examined the 
percutaneous implant to which the BAHA is attached Presented are the clinical 
findings of 68 implants in 65 patients, including six adolescents, from two Dutch 
centers Such aspects, as the implantation depth, stability, and reactions of the 
surrounding skin were examined The patient selection and audiologic results 
have been published elsewhere 2 ' 
The introduction of the titanium implant system by Brânemark and colleagues 
represented an important breakthrough in establishing permanent reaction-free 
penetration of the skin A 5 The percutaneous implant, applicable in dental and 
craniofacial rehabilitation, consists of two parts a titanium fixture anchored in 
the skull and, attached to it, the percutaneous abutment 
The titanium fixture 
With the use of inert titanium implant material, 'osseo-integration' can be 
achieved under certain conditions 6 7 8 The original concept of osseo-integration 
involves a situation in which the whole surface of a certain implanted material is 
in direct contact with the living bone tissue without an intermediate connective-
tissue layer 9 '° This results in long-term stability and the capacity to withstand 
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load and stress from various directions " The titanium fixture and the percuta-
neous abutment are placed in two separate surgical stages on the assumption 
that it is necessary to wait until primary anchoring of the fixture has occurred 
before any stress is applied with the percutaneous abutment61i '2 The first clinical 
trials with percutaneous titanium implants in the mastoid region of the temporal 
bone for coupling of the BAHA were initiated in Goteborg, Sweden '3 '4 The 
percentage of fixtures anchored in the skull bone in the various Swedish studies 
(maximum of 167 implants with a maximum follow-up of 138 months and an 
average of 38 months) varied between 98% and 100% 8 '215 '6 Clinical studies 
from other groups reported the placement of 6 to 23 implants '7 '8 '92° Two of 
these studies (9 and 12 implants) reported a success rate of 100% l7 '8 
The percutaneous abutment, skin reactions 
Reducing the relative movement of the tissue in relation to the percutaneous 
implant is necessary to achieve a permanent reaction-free percutaneous connection.5 
This effect is achieved by binding the skin to the underlying bone by reducing the 
amount of subcutaneous connective tissue, which is feasible and effective on the 
skull '4 Lowering the skin around the abutment also reduces the chance of epithelial 
debris or crusts being trapped between the abutment and the skin and acting as 
foreign bodies The soft tissues adhere to the implant, forming a biological seal 
against the infiltration of micro-organisms 56The results of the percutaneous 
connection can be impaired by general skin disorders, such as seborrhoeic eczema 
and psoriasis, previous radiation treatment, and poor hygiene."2' 
In studies from the Goteborg group, no or only slight irritation of the skin was 
seen in 96% and 97 5% of the observations,12 IS or in 85% of the implants l6 Pro-
longation of the follow-up period did not imply an increase in the frequency of 
skin reactions lfl 
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MATERIAL AND M E T H O D S 
The BAHA was first used at the University Hospital Nijmegen (the Netherlands) 
in 1988 (clinic 1) and at the Diaconessenhuis in Eindhoven (the Netherlands) in 
1989 (clinic 2) Results are given for 65 patients, 24 women and 41 men, who 
received an implant for the BAHA (33 patients from clinic 1 and 32 patients from 
clinic 2) Informed consent was obtained of all patients after the nature of the 
procedure was explained The reason for choosing a BAHA was a draining ear 
(chronic otitis media, 55 patients, chronic otitis externa, four patients) or a 
congenital anomaly (ear canal atresia) that was considered to be inoperable (six 
patients) The age of the patients at the first stage of the operation varied from 
10 to 82 years with an average of 50 years Only the patient group from clinic 1 
included adolescents six patients between 10 and 16 years of age The average 
air conduction hearing thresholds in the best ear at 500, 1000, and 2000 Hz 
varied from 30 to 108 dB, with an average of 66 dB The average unmasked 
bone conduction thresholds at 500, 1000, and 2000 Hz varied from 1 to 65 dB, 
with an average of 30 dB Sixteen of the 65 patients had unilateral hearing 
The implantation was performed once in 62 patients and a second time in three 
patients, making a total of 68 implantations Eight of the 68 implantations were 
conducted in the six adolescents The patients were operated on under general or 
local anaesthetic, depending on the patient's wishes and the preference of the 
surgeon The placement of the percutaneous implant with transpositioning of 
autologous skin (free of hair follicles) was performed in two stages with an 
interval of 4 months The depth and nature of the base of the hole drilled to 
hold the fixture were noted The surgical technique has been described in detail 
by Tjellstrom 8 
After a recovery period of about 1 month, the BAHA was fitted In the subse-
quent follow-up period, the patients at clinic 1 were seen at least once every 4 
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Table 1. Classification of skin reactions aaoicling to Holgeis et al '5 modijied 
0 = No irritation 
1 = Slight redness 
2 = Red and moist tissue 
3 = Red and moist tissue and/or granulation tissue, revision surgery 
necessary 
4 = Abutment removed as a result of an inflammatory reaction 
months and at clinic 2 at least once every 3 months Whether the fixture was 
anchored in the temporal bone and whether the abutment was adequately fixed 
to the fixture were evaluated This was checked by a manual test or by 
attempting to turn the implant using the special screwdriver 
With the use of an operating microscope, epithelial debris or crusts, if present, 
were removed Two issues were noted possible (inflammatory) skin reactions 
and the general condition of the skin around the abutment The skin reactions 
were given a score by the classification presented in Table 1, modified from 
Holgers et al15 Any visible circumstances of the skin around the implant that 
were suspected of having a negative influence with regard to the onset of skin 
reactions, were noted separately (only at clinic 1) In addition to a loose 
abutment, which allows movement in relation to the skin, these conditions 
included thick skin around the abutment, which allows movement in relation to 
the implant and entrapment of debris, and poor skin condition due to skin 
disease 
Regarding the anchorage of the fixtures, the follow-up period for 68 implants 
ranged from 8 to 45 months beginning after the first surgical stage (total follow-up, 
1502 months) Regarding the occurrence of skin reactions, the follow-up period for 
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Figure la. Number of implants (N) of clinic 1 with a certain skin reaction 
versus the follow-up period. 
65 implants ranged from 3 to 40 months (total follow-up, 1162 months) beginning 
after the recovery period of 1 month after the second surgical stage (Figures la and 
lb). Three implants in patients at clinic 2 had just completed the recovery period 
and were not included in the study of skin reactions. 
R E S U L T S 
The stability of the fixture 
The titanium fixture was placed 4 mm deep into the skull in five of the eight 
implants in adolescents and in 46 of the 60 implants in adults; because of a thin 
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Figure lb. Number of implants (N) of clinic 2 with a certain skin reaction 
versus the follow-up period. 
temporal bone in two of the eight implants in adolescents and in 10 of the 60 
implants in adults, the fixture was placed 3 mm deep; in five patients the depth was 
not noted. The nature of the bottom of the drilled hole was noted only at clinic 1. In 
21 of the 36 implants it consisted of bone and in seven of dura; for eight other cases 
it was nol mentioned. The postoperative recovery period of 1 month was uneventful 
in all the patients. Only two of the 68 implanted fixtures were lost. In one adolescent, 
this occurred after a fall, and in another the loss was due to a severe inflammatory 
reaction around the implant site. In the latter case, the subcutaneous tissue reduc­
tion was not optimal and possibly the care of the implant was inadequate. Both 
patients underwent reimplantation successfully. In one adult the fixture was found 
to be loose during follow-up, but after 1 month without being loaded with the 
hearing aid, the fixture had become firmly reanchored, and was still stable after an 
additional follow-up of 8 months. The total number of fixtures retained in the skull 
was 66 (97%) of 68. 
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Table 2. Number of implants and total follow-up at the two clinics and the dis­
tribution of skin reactions. 
Number of implants 
Total follow-up (months) 
Reaction type 0 
Reaction type 1 
Reaction type 2 
Reaction type 3 
Reaction type 4 
Total number of 
observations 
Adolesc. 
8 
152 
33 
2 
2 
0 
1 
38 
Clinic 1 
Adults 
28 
500 
117 
5 
1 
2 
0 
125 
Clinic 2 
Adults 
2^ 
510 
164 
2 
3 
1 
0 
170 
Total 
· · . 65 
Τ162 
314 
9 
6 
3 
1 
333 
The percutaneous abutment, skin reactions 
Table 2 gives an overview of the skin reactions around the titanium abutment, 
scored as outlined in Table 1. If a patient was seen more than once in a follow-
up period of 3 (clinic 1) or 4 months (clinic 1), only the highest reaction type 
was noted as an observation (Table 2). In this study, reaction type 1, 2, 3, or 4 
never occurred simultaneously in one patient in one follow-up period of 3 or 4 
months. In the above-mentioned adolescent, reaction types 1, 2, and 4 were seen 
in three successive follow-up periods before the loss of the implant. Potentially 
dangerous reactions that threatened the retention of the abutment (reactions 2, 
3, and 4) were scored in 10 observations in nine of the 65 implants during a 
total follow-up period of 1162 months. 
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The treatment of skin reactions, depending on the severity of the reaction, 
consisted of regular cleaning of the skin around the implant, the prescription of 
an antibiotic or anti-inflammatory ointment to be applied locally, supplemented 
by a systemic antibiotic if necessary, and in some cases the advice not to load 
the implant with the hearing aid Granulation tissue was excised In all patients 
except the adolescent described above, this treatment proved to be adequate 
Figure 1 shows the cumulative number of implants, the number of implants with 
a skin reaction, and the reaction type from both clinics against the length of the 
follow-up period At clinic 1, there were 27 implants with a minimum follow-up 
period of 1 year, and 10 skin reactions were seen (in 8 implants), 12 of these 
implants had d follow-up period of at least another year, and during this period 
only one skin reaction was seen There was no statistically significant difference 
between the first year and the second year (χ = 1 09, ρ > 05) At clinic 2, there 
were four skin reactions in 25 implants in the first year and two skin reactions in 
10 implants in the second year, the difference was not statistically significant 
(χ = 0 045, ρ > 05) 
Figure 2 presents the percentage 'survival' of implants with intact skin, ie, the 
cumulative percentage of implants in which the patient did not suffer any 
adveise skin reactions throughout the follow-up period,plotted against the length 
of the follow-up period The life table method described by Cutler and Ederer" 
was used to calculate these cumulative percentages The cumulative percentage 
of implants with intact skin and the number of implants followed (for a given 
time interval), were used to calculate the effective sample size (see Cutler and 
Ederer") The number of implants followed and effective sample size were (for a 
given time interval) tested against any two corresponding results from any other 
patient group by comparing the best approximating 2 x 2 contingency table and 
applying an χ test tested at the 5% level There were no statistically significant 
differences between the data of the three patient groups (adolescents, adults at 
clinic 1, and adults at clinic 2) 
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Figure 2. Cumulative percentage of implants remaining free of skin reaction 
by follow-up period 
Table 3 shows the conditions of the skin around the implant observed at clinic l 
that were assumed to have an unfavourable effect with regard to the onset of 
skin reactions Movement of the abutment in relation to the skin was seen in 8 
implants (7 with a loose abutment and 1 with a loose fixture), thick skin around 
the abutment was seen in 1 implant, and poor general condition of the skin was 
seen in 4 implants. In 5 implants a combination of these unfavourable circum­
stances was observed In the remaining 18 implants, the skin around the implant 
was normal. In table 3 the 13 observed skin reactions are divided over the 
various types of circumstances Ten skin reactions occurred in 8 of the 18 
implants with unfavourable circumstances, and 3 skm reactions occured in 3 of 
the 18 implants with normal circumstances. This difference is statistically not 
significant (χ : = 2 10, ρ > .05) The average follow up per implant of these two 
groups did not differ. 
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Table 3. Correlation between implants with normal or unfavourable circumstances 
of the surrounding skin (total 36 implants) and the occurrence of skin 
reaction (total 13 skin reactions). 
Circumstances around the abument 
Normal Unfavourable 
Number of 
implants 
Number of 
skin reactions 
Movement 
Abutment 
Thick Poor skin Combination 
skin condition 
Skin reaction 
type 1,1,3 1,2,3 1,1,2,2,4 
A total of 4 abutments were lost or removed, two of them in relation to the 
above-mentioned loss of two fixtures. In one patient with a heavily-built neck, 
the subcutaneous tissue at the implantation site was 15 mm thick. After 
originally successful reduction of the subcutaneous connective tissue, the skin 
and subcutis thickened and threatened to cover the abutment. The abutment was 
subsequently removed and a second percutaneous implant was placed success-
fully 2 cm higher. In the fourth patient, the abutment was replaced because it 
kept coming loose. A technical analysis of the abutment and the connecting 
screw could not point out any irregularities. 
42 
Clinical results percutaneous implants 
D I S C U S S I O N 
The 97% success rate for anchored fixtures achieved in the present study agrees 
with the earlier research results published in the literature 8 '215 '617 '" The average 
follow-up of the 68 implants was 22 months In 56 (86%) of the 65 implants 
with an average follow-up of 18 months, no skin reactions occurred that threat-
ened the implant, this is in agreement with earlier studies '21516 The percutaneous 
connection appeared to be associated with only a low risk of complications 
In conformity with an earlier study,16 an increasing follow-up period did not 
mean an increase in the frequency of skin reactions It can be concluded from 
the present study that time did not play any significant role in the occurrence of 
skin reactions and that a permanent percutaneous implant is feasible 
In the period after implantation, it is sometimes difficult to distinguish between 
skin reaction types 0 and 1 because in some patients the transplanted skin 
around the implant can retain a reddish color for longer than the recovery 
period of 1 month in a stable situation Reaction types 2, 3, and 4, which can 
threaten the implant, are nearly always noticed by the patients, whereas slight 
redness of the skin as a result of a reaction (type 1) sometimes goes unnoticed 
and may therefore have occurred more frequently The 'survival curves' of the 
implants in this short-term study did not differ significantly by clinic or between 
adults and adolescents from clinic 1 (Figure 2) 
At clinic 1, the presence of one or more unfavourable circumstances of the skin 
around the abutment, ie, movement of the skin in relation to the titanium or 
vice versa (as is the case with thick skin around the abutment or a loose abut-
ment) or poor condition of the skin resulting from skin disease, was observed in 
half of the implants Although more implants in this group suffered a skin reac-
tion than in the group of implants with normal circumstances, the difference was 
not significant Nevertheless, in the literature these unfavourable circumstances 
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are regarded as an important factor with regard to the occurrence of skin reac-
tions.3821 It is therefore necessary to prevent such unfavourable circumstances 
from occurring and, if necessary, to provide adequate treatment. The surgeons 
at the two clinics have gradually started to reduce the subcutaneous tissue 
around the abutment more extensively, which, in combination with more empha-
sis on personal care for the implant and the intensive treatment of skin disease, 
is expected to reduce further the number of skin reactions. As trauma was re-
sponsible for the loss of one implant and for three of the seven loose abutments, 
it is also advisable to lake protective measures during sports with a risk of blows 
to the head. It can be concluded that the results achieved so far support the 
follow-up results of other studies. 
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INTRODUCTION 
The majority of patients who require a hearing aid can be fitted with an air con-
duction hearing aid (ACHA) If an ACHA cannot be used because of recurrent 
otorrhoea or (congenital) atresia of the aural canal, it may be possible to fit a 
bone conduction hearing aid An alternative for the conventional bone conduc-
tion hearing aid (CBHA) is the Bone Anchored Hearing Aid (BAHA) which is 
coupled to a percutaneous titanium implant anchored in the temporal bone ' In 
this way, direct transmission of sound to the skull is established The percuta-
neous implant forms the central issue in the present study 
The titanium implant consists of two parts a titanium fixture which is inserted 
into the temporal bone, and an abutment which is screwed to the fixture and 
penetrates through the skin The BAHA is attached to the implant by means of 
the abutment The technique of implantation of titanium implants emanated 
from dentistry 2 Osseointegration of these implants can be achieved under certain 
circumstances,34 which results in long-term stability and the capacity to with-
stand load and stress ' The forces applied during masticatory function to dental 
superstructures fixed to the implants in the jaw, necessitate a high capacity to 
withstand load and stress In view of the magnitude of these forces, it is still 
considered necessary to place the titanium fixture and the permucosal abutment 
in two separate surgical stages Primary anchorage of the fixture should occur 
before any stress is applied with the abutment, to ensure long-term stability of 
the implant36 
A two stage surgical procedure has also been introduced to insert a percuta-
neous implant into the temporal bone for the coupling of a BAHA or an 
auricular prosthesis 7 Studies performed in Goteborg where the first clinical trials 
were initiated68910 and studies performed by other groups" p n reported that 97 
to 100% of the implants were anchored successfully in the temporal bone 
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Approximately 85% of the implants remained free from skin reactions which 
could endanger the stability of the implant after a mean follow-up per implant 
of 18 months11 and 38 months l0 
The load on the implant used for the BAHA is much lower than the load on 
intra-oral implants and it is more constant in direction and magnitude In the 
light of this fact and the clinical results of the two stage surgical procedure, a 
new surgical technique was developed in Goteborg in 1989, in which both the 
fixture and the abutment were implanted in a one stage surgical procedure In 
this way, the fixture is loaded with the abutment and the BAHA 3 to 4 months 
earlier than with the two stage procedure Recently, the results of a study 
performed in Goteborg were presented at an international workshop, in which 
72 implants for the BAHA had been placed in a one stage procedure The 
results demonstrated that the stability of the implant and the frequency of adverse 
skin reactions were very similar to those obtained with the two stage surgical 
procedure Partial graft necrosis (10%) and minor defects (10%) were observed 
which all healed completely without delaying the fitting procedure lA Shortly 
after the first encouraging results from Goteborg were reported,15 an alternative 
one stage surgical technique was developed in Nijmegen 
In this study, the preliminary clinical results of the one stage surgical procedure 
performed by the senior author are presented The clinical results of percuta-
neous implants placed in a two stage surgical procedure in Nijmegen and 
Eindhoven have been presented elsewhere n Some of the data from that study 
were updated and used in this study for comparison with the results of the one 
stage surgical procedure 
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MATERIAL AND M E T H O D S 
Swgical pioceduie 
The implantation of implants for the BAHA was introduced in the Netherlands 
by the senior author in 1988 At first, implants were placed in a two stage 
surgical procedure (36 implants in 33 patients) The two stage surgical technique 
was described in detail by Tjellstrom * The first surgical stage consisted of 
placing the titanium fixture with a length of 3 or 4 mm, depending on the 
thickness of the cortical bone, in the temporal bone The second surgical stage, 
performed 3 to 4 months later, consisted of transpositioning a thinned 
autologous skin graft from behind the earlobe (free from hair follicles) to the 
area over the fixture The subcutaneous tissue around the implant site was 
reduced This skin graft was subsequently punctured and a percutaneous 
abutment was fixed on to the fixture using a connecting screw Since early 1991, 
these surgical stages have also found application in one operation in Nijmegen 
Figures la to If show the surgical procedure of the one stage operation as 
performed in Nijmegen The procedure is generally performed under local anaes-
thesia and with an oral sedative and intramuscular pethidine Aflei the surgical site 
has been prepared in the usual way, the tissue including the periosteum is infiltrated 
with local anaesthetic A longitudinal incision of 3 to 4 cm is made over the intended 
implant site ÍFigui e la) After sharp dissection of the subcutaneous tissue, the 
periosteum is exposed and removed over an area of 1 to 2 cm around the intended 
implant site The drilling procedure and insertion of the fixture and the abutment 
are performed as described by Tjellstrom 8 After drilling with slowly rotating burrs 
and abundant irrigation with saline solution to a depth of 3 or 4 mm, the fixture is 
inserted (Figure lb) If it is clear during control tightening that the fixture is firmly 
embedded in the bone tissue, preparations can be made for the placement of the 
percutaneous abutment After extensive reduction of the subcutaneous tissue over 
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Figure la. A longitudinal incision of 3 to 4 cm over the intended implant site 
an area of 2 cm around the fixture (Figure h J, a free skin graft (free from hair 
follicles) іь transpositioned from the retroauncular fold, thinned and sutured over 
the fixture (Figwe Id) Scar tissue in the skin graft as a result of an earlier ear 
operation, need not be an objection 
The skin (graft) around the implant then makes direct contact with the bone 
tissue A punch is used to puncture the graft and the abutment is placed on the 
fixture, which penetrates through the skin graft (Figure le) A healing cap is 
fitted over the abutment with gauze soaked in antibiotic ointment packed 
between the skin and the cap The caudal end of the longitudinal incision is left 
open to allow the wound to drain Owing to the fact that the length of the 
longitudinal incision is larger than the diameter of the healing cap, a pressure 
dressing is applied around the head immediately after the operation to avoid the 
51 
Chapter 3 
Figure lb. The fixture is inserted into the bone after the periosteum has been 
removed 
development of haematoma. The next day, the pressure dressing is replaced by a 
dressing to protect the wound. In this way, the transplanted skin is left to adapt 
to the bone tissue for 6 days (Figure If). Subsequently the healing cap and 
gauze are removed and are not replaced. Further treatment consists of the 
application of an antibiotic or anti-inflammatory ointment every (other) day. 
P A T I E N T S 
Thirty-three patients, 20 women and 13 men, were implanted in a one stage 
operation in the period between January 1991 until August 1992. The indications 
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Figure lc. Reduction of the subcutaneous tissue around the fntuie 
for a bone conduction hearing aid were a draining ear (chronic otitis media 28 
patients, chronic otitis externa 1 patients) which did not react to conservative 
therapy, for which there were no surgical options and which was sustained by 
blockage of the ear canal by an ACHA, or a congenital anomaly which was 
considered to be inoperable (2 patients) The age of the patients varied from 15 
to 76 years with an average of 50 years The average air conduction threshold in 
the best ear at 0 5, 1 and 2 kHz was 65 dB HL (18 to 91 dB HL) and the average 
bone conduction threshold at 0 5, 1 and 2 kH/ was 27 dB HL (8 to 48 dB HL) 
The clinical results in this group of patients were compared to those in a group 
of patients implanted in a two stage operation The clinical results of the 
implants in the latter patient group, concerning 16 implants in 33 patients, have 
been presented elsewhere n 
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Figure ld. Transplantation of a free skin giaft from the retroauncular jold 
The caudal end oj the longitudinal incision is left open to allow the 
wound to dram 
Follón-up 
After a recovery period of 4 to 6 weeks, the BAHA was fitted. In the subsequent 
follow-up period, the patients had a check-up at least once every four months in 
which it was evaluated whether the fixture was firmly anchored in the temporal 
bone and whether the abutment was connected securely to the fixture This was 
checked manually or by attempting to turn the implant with a special titanium 
screwdriver An operation microscope was used to remove any epithelial debris 
or crusts, if present Any (inflammatory) skin reactions around the abutment 
were recorded The skin reactions were given a score using the classification 
described in Table 1, modified from Holgers et al.9 If more than one observation 
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Figure le. The skm graft is punctured and the abutment is saeued on to the 
fixture I he ikm around the implant u, ¡n direct contact with the 
bone tissue 
was made during a follow-up period of four monlhs, only the most severe skin 
reaction type was used for the study 
RESULTS 
The total follow-up period of the 33 implants was 501 months, including the 
postoperative recovery period of one month The follow-up per implant varied 
between 9 and 25 months The recoveiy period was uneventful in all but one of 
the patients This patient was undergoing treatment with an anticoagulant drug 
following a heart attack a few days after the placement of the implant under 
general anaesthesia As a result, a large haematoma formed under the autolo-
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Figure If. The transplanted skin is left to adapt to the hone tissue for 6 days 
coveied hv gauze soaked in antibiotic ointment and a healing cap. 
gous skin transplant. After the application of a pressure dressing, recovery was 
good. However, the patient complained about severe pain around the titanium 
implant throughout the follow-up of 8 months Necrosis of the autologous skin 
graft did not occur in any of the patients 
Two of the 33 implanted fixtures were lost. In one adolescent patient with the 
Treacher Collins syndrome, the Fixture was lost two months after implantation 
due to a severe inflammatory reaction around the implant site. This was the 
Table 1. Classification of skin reactions, modified J'rom Holgers et al'' 
0 = No irritation 
1 = Slight redness 
2 = Red and moist tissue 
3 = Red and moist tissue and/or granulation tissue, revision surgery 
necessary 
4 = Abutment removed as a result of an inflammatory reaction 
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patient's second implant for the BAHA The first implant, which had been 
placed in two stages, had been removed because it was not mechanically possible 
to adequately connect the abutment to the fixture In another patient, the fixture 
had become unstable after a trauma The patient had continued to load the 
implant with the BAHA for one month directly after the trauma which had 
impeded reanchoring of the implant 
Even after a period of six months without being loaded with the hearing aid, the 
implant did not reanchor in the temporal bone The latter patient was reimplant-
ed successfully the former was awaiting reimplantation The total number of 
fixtures implanted in one stage and retained in the skull was 31 (94%) of the 33 
Figure 2 shows the cumulative number of implants and the type of skin reaction 
(Table 1 ) observed during the follow-up period Skin reaction type 4 was only 
observed in the above-mentioned Treacher Collins patient which led to the loss 
ot the whole implant Skin reaction type 2 was observed 7 times in 6 implants 
and required local treatment with an antibiotic or anti-inflammatory ointment, 
sometimes supplemented by a systemic antibiotic depending on the severity of 
the reaction Skin reaction type I which sometimes went unnoticed by the 
patient, was observed 11 times in 8 implants and skin reaction type 3 was never 
observed Thus, 26 (79%) of the 33 implants remained free from potentially 
dangerous skin reactions (type 2, 3 or 4) in a total follow-up period of 468 
months All the patients with a skin reaction had more frequent check-ups 
temporarily and could be treated adequately 
The life table method descnbed by Cutler and Ederer16 was used to calculate the 
cumulative proportion (%) of implants who did not suffer from any skin reac-
tion (skin reaction type 1, 2, 3 or 4) throughout the follow-up period (Table 2) 
In the life table method, the number of implants followed per time interval do 
not include the implants which suffered a skin reaction in any of the previous 
time intervals The survival curves of the implant groups implanted in one stage 
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Figure 2. Number of implants (Ν) with a certain type of skin reaction in the 
follow-up intervals. 
and in two stages derived from Table 2, are presented in Figure 3. The cumula­
tive percentage of implants with intact skin with its standard error and the 
number of implants followed (for a given time interval) were used to calculate 
the effective sample size. The number of implants followed and the effective 
sample size of the group of implants placed in one stage were (for a given time 
interval) tested against any two corresponding results for the group of implants 
placed in the two stage operation by comparing the best approximating 2 x 2 
contingency table and applying an χ2 test tested at the 5% level. No statistically 
significant differences were found between the data for these implant groups. 
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Table 2a. Life Table according to Cutler and Ederer16 of 33 implants placed in a 
one stage procedure. 
Interval 
period 
(mths) 
0-4 
4-8 
8-12 
12-16 
16-20 
20-24 
Number of 
implants 
followed 
33 
26 
17 
10 
6 
3 
Number 
of 
reactions 
7 
3 
1 
0 
0 
0 
Proportion 
within 
interval 
79% 
88% 
94% 
100% 
100% 
100% 
Cumulative 
proportion 
79% (100% χ 79%,) 
70%> (79% χ 88%) 
66% (70% χ 94%) 
66%. (66% χ 100%) 
66% (66% χ 100%) 
66% (66% χ 100%) 
Effective 
sample 
size 
26 
18 
11 
7 
4 
3 
Table 2b. Life Table according to Cutler and Ederer16 of 36 implants placed in a 
two stage procedure. 
Interval 
period 
(mths) 
0-4 
4-8 
8-12 
12-16 
16-20 
20-24 
Number of 
implants 
followed 
36 
31 
28 
23 
22 
21 
Number 
of 
reactions 
3 
3 
5 
0 
1 
2 
Proportion 
within 
interval 
92% 
90% 
82% 
100% 
96% 
90% 
Cumulative 
proportion 
92% (100% χ 92%) 
83% (92% χ 90%) 
68% (83% χ 82%) 
68% (68% χ 100%) 
65% (68% χ 96%) 
59% (65% χ 90%) 
Effective 
sample 
size 
33 
26 
19 
16 
14 
12 
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Figure 3. Cumulative proportion ( P) of implants which remainedfree Ji om skm 
ιeattion \eisus the follow-up interval 
DISCUSSION 
Three features of the one stage procedure followed in this study distinguish the 
surgical technique from others reported at seminars '' '7 Firstly, the use of a 
longitudinal incision, in our view, enables the surgeon to reduce the subcutaneous 
tissue around the implant site more extensively than the use of a semicircular 
incision As has been stressed in the literature, maximum reduction of the 
subcutaneous tissue is necessary to achieve solid and close attachment of the 
skin to the periosteum or, as was the case in this study, to the bone tissue in 
order to reduce movement in relation to the implant and reduce the entrapment 
of debris between the skin and the abutment This is vital for the prevention of 
skin reactions.7 '2 " Secondly, the surgical technique involved the removal of the 
periosteum As of yet it is not clear whether the attachment of the skin graft to 
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bone tissue is better than the attachment to the periosteum, nor is it clear which 
of the two tissues contributes most to the vasculansation of the skin graft 
Thirdly, the tamponnade with the healing cap was left in place for a short 
period of time (6 days) It remains to be seen whether necrosis of the skin graft 
(if it occurs) is the result of insufficient adaption of the graft to the underlying 
tissue which may facilitate the development of haematoma or may result m 
insufficient vasculansation of the graft from below, or whether it is the result of 
applying pressure for too long and impeding the vasculansation of the graft 
After a total follow up of 501 months, 31 out of the 33 fixtures (94%) placed in 
a one stage procedure were anchored in the skull The mean follow-up of 15 2 
months of these implants was too short to make a general statement about the 
possibility of replacing the two stage technique However, the percentage of 
fixtures anchored in the skull in this study was comparable to that achieved with 
the two stage implantation procedure (97% after a mean follow-up of 22 
months) n The preliminary results of the one stage surgical technique demon-
strate stable fixation The one stage surgical technique used at our clinic led to 
the same degree of fixture stability as that achieved at other clinics However, it 
must be noted that there was a difference in the total follow-up between clinics 
In contrast with the results from other clinics reported at seminars,14 '7 complete 
or partial necrosis of the skin graft was not seen in any of our patients in the 
postoperative period 
The life table method and the survival curves have proved to be a practical 
instrument to compare the behaviour of groups of percutaneous implants with 
regard to skin reactions when the follow-up of the implants differed Although 
the data of the survival curve of one stage implants did not differ significantly 
from those of the two stage implants in any follow-up period during the first 
year, the cumulative proportion of one stage implants which did suffer from skin 
reactions during the first 8 months was higher than that among the two stage 
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implants It is possible that the initial higher occurrence of skin reactions with 
the one stage implantation technique resulted from the fact that the fixture was 
loaded with the abutment and the hearing aid at an earlier stage in the osseo-
ïntegration process than in the two stage technique Consequently, the anchorage 
of the fixtures may have been less rigid at the time of hearing aid fitting one 
month after the implantation At this stage, healing of the bone tissue was still 
in progress, which may have allowed more movement in relation to the skin and 
led to more skin reactions After about 12 months the survival curves converged 
(Figuie 3), which indicates that it will be interesting and worthwhile to obtain 
the long-term results It may be possible to replace the two stage technique in 
the future 
C O N C L U S I O N 
The one stage surgical technique of inserting a percutaneous implant into the 
temporal bone using a free retro-auricular skin graft and removing the perios-
teum at the implant site, led to good postoperative results For the first two 
years of follow-up, the clinical results of the one stage procedure were statistical-
ly comparable to the two stage procedure evaluated at the same clinic These 
preliminary results are promising in relation to shortening the rehabilitation time 
of the patient and reducing the financial cost 
62 
A one stage surgical procedure 
REFERENCES 
1. Hâkansson В, Tjellslröm A, Rosenhall U. Carlsson P. The Bone Anchored Hearing Aid: 
principle design and a psychoacoustical evaluation. Acta Otolaryngol (Slockh), 1985; 100: 229-239 
2. Bránemark P-I, Breine U, Adell R, Hansson BO, Lindström J, Ohlsson A. Inlra-osscous 
anchorage of dental prostheses. 1. Experimental studies. Scand J Plast Reconslr Surg, 1969; 
3: 81-100. 
3. Albrektsson T, Bránemark P-I. Hansson H-Α, Lindström J. Osscointcgrated titanium implants. 
Requirements for ensuring long lasting, direct bone-to-implanl anchorage in man. Acta Orthop 
Scand, 1981; 52: 155-170. 
4. Lindström J, Bránemark P-l, Albrektsson T. Mandibular reconstruction using the preformed 
autologous bone graft. Scand J Plast Rcconstr Surg, 1981; 15: 29-38. 
5. Adell R, Lckholm U. Rockler B, Bránemark P-I. A 15 year study of osseointegrated implants in 
the treatment of the edentulous jaw. Int J Oral Surg, 1981; 10: 387-416. 
6. Albrektsson T, Bránemark P-l, Jacobsson M, Tjellström A. Present clinical applications of 
osseointegrated percutaneous implants. Plast Reconstr Surg, 1986; 79: 721-730. 
7. Tjellström Α. Rosenhall U, Lindström J, Hallen О, Albrektsson Τ, Bránemark P-l. Five-year 
experience with skin penetrating bone anchored implants in the temporal bone. Acta Otolaryngol. 
1983; 95: 568-575. 
8. Tjellström A. Percutaneous implants in clinical practice. CRC Critic Rev Biocompatibility, 1985; 
1: 205-228. 
9. Holgers K-M, Tjellström A, Bjursten LM, Erlandsson B-Ε. Soft tissue reaction around percuta­
neous implants', a clinical study of soft tissue conditions around skin-penetrating titanium 
implants for bone anchored hearing aids. Am J Otol. 1988: 9: 56-59. 
10. Hâkansson В, Liden В, Tjellström A. Ringdahl Α, Jacobsson M. Carlsson P. Erlandsson BE. 
Ten years of experience with the Swedish bone anchored hearing system. Ann Otol Rhinol 
Laryngol, 1990; 99 (suppl 151): 1-16. 
11. Abramson M, Fay TH, Kelly JP, Wazen JJ, Liden G, Tjellslröm A. Clinical results with a 
percutaneous bone anchored hearing aid. Laryngoscope, 1989; 99: 707-710. 
12. Bonding P. Ahlgren P. Dige-Pelersen H. Permanent, skin penetrating, bone anchored titanium 
implants. A clinical study of host reaction in bone and soft tissue. Acta Otolaryngol (Slockh), 
1992; 112: 455-461. 
13. Mylanus EAM, Cremers CWRJ, Snik AFM, Van den Berge NW. Clinical results of percuta-
neous implants in the temporal bone. Arch Otolaryngol, 1994; 120: 81-85. 
14. Tjellström A, Granström G. The one stage procedure for implant in the mastoid. Book of 
abstracts. Third international winter seminar implants in craniofacial rehabilitation and audiolo-
gy. Selva Val Gardena, 1993: 46. 
15. Tjellström A. A one or a two stage procedure? Book of abstracts. First international winter 
seminar on implants in craniofacial rehabilitation and audiology. Lech am Arlbcrg, 1991; 36. 
16. Cutler SJ. Ederer F. Maximum utilization of the life table method in analyzing survival. 
J Chronic Dis, 1958; 8: 699-712. 
17. Proops DW, Wake MJC. A single stage technique for the BAHA. Book of abstracts. 
Third international winter seminar on implants in craniofacial rehabilitation and 
audiology. Selva Val Gardena, 1993; 45. 
18. Bránemark P-I, Albrektsson T. Titanium implants permanently penetrating human skin. 
Scand J Plast Reconstr Surg, 1982; 16: 17-21. 
63 
64 
Chapter 
4 
Audiological results of the Bone Anchored 
Hearing Aid HC200, multicentre results 
Emmanuel AM Mylanus, MD, Ad FM Snik, PhD, 
Cor WRJ Cremers, MD, PhD, Frank F Jorritsma, Ir Hans Verschuurc, PhD 
Annals of Otology Rhinology & Laryngology 
1994; 103: 368-374 
Chapter 4 
66 
Audiological results ВАНА НС200 
I N T R O D U C T I O N 
The majority of patients with hearing loss who cannot be treated surgically need to 
be fitted with a hearing aid, mostly an air conduction hearing aid (ACHA). In some 
patients, blocking the auditory canal with the earmould of an ACH A causes inflam­
mation of the middle ear or auditory canal due to insufficient ventilation. Further­
more, congenital atresia of the auditory canal or congenital auricular malformation 
can make it impossible to fit an ACHA. A solution for such patients is to use a 
(conventional) bone conduction hearing aid (CBHA). The bone-conductor is 
attached to a headband or mounted in a spectacle frame to position it against the 
mastoid process of the temporal bone with a constant pressure. Although in most of 
the patients the result is satisfactory with a CBHA, there are some disadvantages, 
e.g. variation in speech recognition caused by variation in the pressure between the 
transducer and the mastoid and the pressure of the transducer itself which can cause 
various complaints, such as local pain, skin irritation and headaches. 
The Bone Anchored Hearing Aid (BAHA), which was developed in Göteborg 
and has been in use there since 1982' is an alternative for the CBHA. The sys-
tem comprises a percutaneous titanium implant anchored in the temporal bone2 л 
and a specially designed transducer which is attached to it. With the BAHA, 
sound transmission to the skull is direct. In this way it is possible to achieve the 
same hearing thresholds as with transcutaneous, conventional bone conduction 
but with a lower output of the transducer4 and therefore less distortion.' 
Since the introduction of the BAHA, several studies have been conducted to 
compare the patients' performance with the BAHA to that with a conventional 
hearing aid (CHA), making use of a standard BAHA and a standard CHA, S 6 7 
or the patients' own BAHA and C H A , 8 9 1 0 " or both.' Especially at frequencies 
of above 2 kHz, improvements have been reported in the free field thresholds 
with the BAHA compared to the CBHA8 " and ACHA.10 Free field speech 
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recognition-in-quiet tests which made comparisons between the BAHA and 
C B H A , 5 6 7 8 " or between the BAHA and ACHA,7 S l i l have shown practically no 
difference in the maximum phoneme score (MPS) or the phoneme score at a 
conversation level 
In most of the studies, speech recognition-in-noise tests were performed too The 
results with the BAHA were found to be comparable'5 7 or better than those 
with the CBHA 8 9 " It has been argued that the relative improvement in the free 
field thresholds in the higher frequency range and the lower level of harmonic 
distortion with the BAHA could be the reasons for improved speech recogni-
tion-in-noise " In comparison with the ACHA, speech recognition-in-noise with 
the BAHA remained the same7 9 or did not improve significantly 8 
This paper presents the audiological results of a group of patients fitted with the 
BAHA HC200 at three Dutch clinics and increases the data base on published 
results with this hearing aid Compared to all the studies previously published, 
this study presents the largest number of patients fitted with a BAHA HC200 
who were evaluated audiologically using a strict protocol Besides comparing the 
results of groups of patients using the BAHA or the CHA, individual results are 
presented and analysed for significance In Experiment I, the patients' perfor­
mance with the BAHA was compared to their performance with the CHA, 
either a CBHA (ВС group) or an ACHA (AC group) by means of free field 
threshold measurement and free field speech recognition tests In Experiment II, 
the tests were repeated on a subgroup of patients using a standard BAHA and a 
standard CBHA This was done to eliminate the type of hearing aid as a 
variable, heanng-aid-related variables eliminated in this set-up were the frequency 
response, the position of the microphone (at the ear or in front of the body 
when using a body level hearing aid) and its monaural or binaural application 
This paper does not address patients whose sensorineural hearing loss compo­
nent exceeded 45 dB HL and would therefore not benefit from the BAHA 
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НС200 A proportion of such patients can be fitted successfully with the 
stronger BAH A HC220 i : 
PATIENT SELECTION 
The selection criteria at the three clinics were identical a hearing aid was 
needed, surgical therapy was not an option, the patient had conductive or mixed 
hearing loss, the average bone conduction threshold at 0 5, 1 and 2 kHz 
(PTAbc) did not exceed 45 dB HL and the minimum age was 10 years hor 
inclusion in the ВС group the patient had to have used a CBHA but experienced 
inadequate speech recognition (criterion 1), local pain, skin irritation or 
headaches (criterion 2) or serious problems with the appearance of the device 
(critenon 3) For inclusion in the AC group the patient had to have used an 
ACHA but could not continue to do so as a result of chronic otitis media 
and/or externa which did not react to conservative therapy and persisted due to 
blockage of the ear (criterion 4) or had to have complained of uncontrollable 
feedback problems (criterion 5) Attempts to fit a CBHA had failed for the same 
reasons mentioned above 
A total of 62 patients were fitted with the ВАНА HC200 29 women and 33 
men (Table 1 ) The history of the patients revealed chronic otitis media in 51 
patients, chronic otitis externa in 3 patients and a congenital malformation of 
the auditory canal in 8 patients The PTAac (average air conduction thresholds 
at 0 5, 1 and 2 kHz) was at least 30 dB HL at the best ear All the patients had 
used а CHA in the past 52 patients a CBHA with an average PTAbc of 18 9 ± 
9 5 dB HL (ВС group) and 10 patients an ACHA with an average PTAbc of 
26 2 ± 13 6 dB HL (AC group) In the ВС group the air-bone gap varied 
between 6 and 65 dB HL, in the AC group it varied between 30 and 65 dB HL 
The ВАНА was indicated in the patient group as a result of criterion 1 in 12 
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Table 1. Characteristics of the patient groups from the three participating clinics 
Clinic η Age PTAac PTAbc Previous CHA 
(yrs) (dB HL) (dB HL) 
42 3 
(10-70) 
51 9 
(29-67) 
47 1 
(18-75) 
57 6 
(30-92) 
55 9 
(43-70) 
57 2 
(30-78) 
18 2 
(1-44) 
23 6 
(7-42) 
23 9 
(12-35) 
ACHA 9 
CBHA 32 
ACHA 0 
CBHA 11 
ACHA 1 
CBHA 9 
η = number of patients, PTAac - average air conduction thiesholds at 0 5 
1 and 2 kHz PTAbc = average bone conduction thresholds at 0 5, I and 2 kHz 
CHA = conventional hearing aid, ACHA - an conduction heating aid, 
CBHA = conventional bone conduction hearing aid mean and range are given 
patients, criterion 2 in 28 patients and criterion 3 in 3 patients In 19 patients 
there was a combination of criteria 1 and 2 A CBHA had been tried in the AC 
group as a result of criterion 4 in 7 patients and a combination of criteria 4 and 
5 in 3 patients 
METHODS 
The best unmasked bone conduction thresholds were used to calculate the 
PTAbc irrespective of the ear at which they were measured, because both 
cochlea are stimulated with a bone conduction hearing aid as a result of the 
small transcranial attenuation of sound conducted by bone After a recovery 
period of four to six weeks, the BAHA HC200 was fitted Several audiological 
tests were performed as soon as the patient and audiologist were satisfied with 
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the result, at least 4 weeks after fitting the BAHA Before testing, all the hearing 
aids were checked for normal functioning and during all the tests the hearing 
aids were used at the normal (daily) volume chosen by the patient 
Experiment I 
Aided free field threshold measurements, speech recognition-in-quiet tests and 
speech recognition-in-noise tests were performed in order to make a comparison 
between the patients' performance with their individually adapted ВАНА HC200 
and their CHA Furthermore, the free field thresholds of the CHA and the 
BAHA were compared to the bone conduction thresholds, to give an impression 
of the ability of the hearing aid to close the air-bone gap The patients were 
divided into four subgroups according to the level of their sensorineural hearing 
component PTAbc < 11 dB HL, 10 < PT Abc < 21 dB HL, 20 < PTAbc < 31 
dB HL and PTAbc > 30 dB HL The cut offs chosen were arbitrary This was 
done to study the influence of the sensorineural hearing component on the 
audiological results with the BAHA 
Experiment II 
As Experiment I compared the patients' performances with individually adapted 
hearing aids, Experiment II was performed to compare the results with the 
BAHA HC200and the CBHA irrespective of the patient For this purpose, speech 
recognition tests were performed using standard hearing aids Nine patients from 
clinic 1, who had used a CBHA in the past, were selected at random to partici­
pate in this experiment in which the same tests were performed as in Experiment 
I The standard CBHA used was an Oticon transducer connected to a body level 
hearing aid Philips S1594, the standard BAHA was a HC200 type WL 
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Statistics 
The Student t-test was used two-tailed at a 5% level for the statistical analysis of 
the differences in average values The Pearsons' correlations between the audio-
logical data and the level of sensorineural hearing loss were tested at a 5% level 
MATERIALS 
At all three clinics, the tests were performed in a special sound-proof room The 
warble tones used to obtain free field thresholds were generated by a standard 
audiometer (Interacoustics AC-5, calibrated according to the ISO 389) with a 
frequency modulation of 5% and were presented by means of a loudspeaker 
placed in front of the patient The free field set-up was calibrated according to 
Morgan el al n F-rcc field thresholds were determined only for the patients from 
clinics 1 and 2 Thresholds were obtained at 0 25, 0 5, 1,2 and 4 kHz 
At clinics 1 and 2, a speech lecognition performance-intensity (PI) function was 
obtained using the tiee field set-up described above and standard Dutch Ρ В 
woid lists consisting of ten monosyllables each Calibration was performed as 
described by Dirks et al N At least six different presentation levels were used 
The maximum phoneme score (MPS) was determined from the PI curve and was 
defined as the highest percentage of correctly repeated phonemes To increase 
reliability, the MPS was determined from two successively determined PI curves 
The significance of a shift in the MPS with the BAHA compared to the CHA 
was verified using the critical difference according to Thornton and Raffin l s 
To measure speech recognition in noise, the test described by Plomp and 
Mimpen" was used at all three clinics This test makes use of lists of thirteen 
sentences, recorded on tape, together with a steady state noise signal (in this study 
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65 dB(A)) with a spectrum equal to the long-term spectrum of the sentences 
The normal value for the speech-to-noise ratio (S/N) is -7 3 dB, with an intra-in-
dividual standard deviation of 1 dB 16 In this study, the difference between two 
S/N ratios was considered to be significant if it exceeded twice the standard 
deviation, being 2 χ 1 χ \Ñ2 = 1 4 dB, the factor 1Л/2 was incorporated because 
the presented S/N values are the average values of (at least) two successive 
measurements 
R E S U L T S 
Experiment I 
A ided ft ее field thresholds 
The aided free field thresholds were determined in 52 patients, all from clinics 1 
and 2 There were 43 patients in the ВС group and 9 in the AC group Figure 1 
shows the average difference in aided free field thresholds (CHA thresholds 
minus BAHA thresholds) in the ВС group plotted separately for clinics 1 and 2 
and the corresponding data in the AC group The difference between clinics 1 
and 2 within the ВС group as presented in Figure 1 was significant at Ü 5 and 2 
kHz (t(41) = 2 88 and 2 61, ρ < 0 01), but not at 0 25, 1 and 4 kHz Combining 
the results of both clinics, it was found that the difference in thresholds was 
significantly positive at 0 5, 1, 2 and 4 kHz (t(42) = 4 52 to 7 41, ρ < 0 01) This 
means that significantly better thresholds were obtained with the BAHA at these 
frequencies In the AC group, the BAHA did not produce a significantly better 
threshold at any of the frequencies 
Figure 2 shows the average aided free field thresholds obtained with the BAHA for 
the four subgroups of patients (see Methods) and presents the speech area 
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Free-field threshold shift (dB) 
0.25 0.50 1 2 
Frequency (kHz) 
Figure 1. Aided free field threshold shift, CHA threshold minus BAH A 
threshold, as a fune tion of frequency foi the ВС group (*) (n - 43) 
and the AC group (0) (n - 9) The results of the ВС group ate 
subdivided according to clinic A positive value indicates improved 
thresholds with the BAH A In the ВС group, the standard deviation 
in the threshold shift varied between 7 1 and 15 4 dB and in the AC 
group it varied between 8 2 and 13 9 dB 
according to Mueller and Kilhon 17 Most of the speech area was covered in the 
subgroup with the smallest sensorineural hearing loss component In the subgroup 
with the largest sensorineural hearing loss component, considerably less of the 
74 
Audiological results ВАНА НС200 
0 
20 
40 
60 
80 
100 
Free-field threshold (dB HL) 
\ /£== \^ / 
хУ^—S^ 
Ν 
ι ι ι ι ι 
0.25 0.50 1 2 
Frequency (kHz) 
β 
Figure 2. Average aided jree jield thresholds in the subgroups of pa tient s with 
a PTAbc < 11 dB HL (χ), with 10 < PTAbc < 21 dB HL (A), 
with 20 < PTAbc < 31 dB HL (О) and with PTAbc > 30 dB HL 
(I) using the BAHA The speech area is indicated according to 
Mueller and Killion '7 
speech area was covered, especially at the higher frequencies The average free field 
thresholds obtained with the CHA for the four subgroups were higher (not 
presented in Figure 2) 
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ВС threshold - FF threshold (dB) 
0.25 0.50 1 2 
Frequency (kHz) 
Figure 3. The bone < onclm tum ( ВС) tin eslwhh minus the aided free field ( FF) 
tin esholds, ι epi esenting the size of the remaining an -bone gap using 
theBAHA (D) (n = 52), CBHA (*) (n = 43) or ACHA (0) (n = 9) 
as a function of Ji equency A positi\e value indicates ovei closui e of the 
cur-bone gap 
To study the closure of the air-bone gap with each type of hearing aid, the aided 
free field thresholds were subtracted from the bone conduction thresholds On 
average the air-bone gap was closed only at 2 kHz with the ACHA and BAHA, 
but not with the CBHA (Figure 3) 
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Table 2. Number of patients in the AC and ВС groups who performed in both 
speech recognition tests and obtained statistically significant results 
MPS and S/N ratio with the AC 
BAHA compared to the CHA group 
Improved MPS, Unchanged S/N ratio 0 
Unchanged MPS, Improved S/N ratio 4 
Improved MPS, Improved S/N ratio 0 
Unchanged MPS, Unchanged S/N ratio 3 
Worsened MPS, Improved S/N ratio 1 
Unchanged MPS, Worsened S/N ratio 1 
Total 
ВС 
group 
2 
22 
3 
15 
0 
0 
42 
Total 
group 
2 
26 
3 
18 
1 
1 
51 
AC group = patients who previously used an air conduction hearing aid; ВС group 
— patients who previously used a bone conduction hearing aid; MPS - maximum 
phoneme score; S/N ratio = speech-to-noise ratio 
Speech recognition tests 
Of the 52 patients tested (clinics 1 and 2), the individual MPS values obtained 
with the BAHA and the CHA were analysed for a significant difference, (see 
Materials). In 5 patients in the ВС group the MPS improved significantly with 
the BAHA, whereas in 1 patient in the AC group the MPS with the BAHA 
deteriorated significantly (Table 2). In the remaining 46 patients the change in 
MPS was not significant. In 21 out of the 52 patients, the MPS was 100% with 
the BAHA and CHA. Table 3 presents group results subdivided according to 
the degree of sensorineural hearing loss. A trend can be observed in which the 
MPS diminishes as the sensorineural hearing loss increases. 
Chapter 4 
Table 3. Average results of the subgroups of patients with different sensorineural 
components in the hearing loss on the speech recognition tests 
MPS (%) S/N ratio (dB) 
Subgroup СНА ВАНА Diff СНА ВАНА Diff 
РТЛЬс<11(х) 9 8 8 ( 3 1 ) 998(08) 10(28) -23(35) -44(2.5) -21(17) 
10 < PTAbc < 21 (Δ) 96 4(4 0) 97 7(3 0) 13(3 6) -0 4(2 6) -18(2 6) -14(17) 
20 < PTAbc < 31 (О) 90 8(9 5) 94 4(6 1) 3 5(6 7) 0 3(4 0) -2 2(3 4) -2 5(3.0) 
P T A b O 30 (Δ) 92 0(7 7) 92 8(8 0) 0 8(8 0) 3 9(4 3) 0 6(3 2) -3 3(4.9) 
The average values and standard deviation are presented, MPS = Maximum 
phoneme score, S/N = speeth-to-noise ratio, Diff = BAH A minus CHA score. The 
symbols between brackets m the first column refer to the symbols used in Figure 2 
All 62 patients participated in the speech recognition-in-noise test. In two 
patients the test was unsuccessful owing to linguistic problems. The average 
improvement in the S/N ratio in the ВС group was -2.3 ± 2.4 dB (t(49) = 6.78, 
ρ < 0.01) and in the AC group -1.7 ± 2.7 dB (ns). Of the 62 patients tested, 34 
improved significantly (using the critical difference, see Materials): 28 patients in 
the ВС group and 6 patients in the AC group. One patient who had previously 
used an ACHA performed significantly worse with the BAHA. In Table 2 the 
results of the patients who performed both speech recognition tests are summa­
rized. Table 3 presents the results of the speech recognition-in-noise lest in the 
four subgroups. The average speech recognition scores were better with the 
BAHA and the CHA in the subgroups with the smaller sensorineural hearing 
loss components. The differences found between the CHA and the BAHA did 
not differ significantly between the subgroups, meaning that the four subgroups 
improved to the same extent. 
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Table 4. Results of the patients who participated in Experiment II on the speech 
lecogmtion tests 
MPS CBHA (%) 
100 
100 
100 
67 
90 
93 
100 
90 
100 
MPS В AH A (%) 
97 
100 
100 
87* 
87 
100* 
100 
100* 
100 
S/N CBHA (dB) 
-1 6 
-0 9 
58 
8 0 
56 
4 1 
-2 8 
4 7 
3 3* 
S/N BAHA (dB) 
-2 7 
-2 5" 
-0 7' 
6 3' 
4 5 
15* 
-4 5* 
4 1 
5 0 
MPS = maximum phoneme score S/N - speech to noise ratio, * = significantly 
better scote 
Expei /ment II 
Table 4 shows the results of the speech recognition tests of nine patients who 
participated in Experiment II In the speech recognition-in-quiet test, the MPS 
of 3 out of the 9 patients improved significantly with the standard BAHA 
compared to the standard CBHA Of the remaining 6 patients, 4 achieved a 
MPS of 100% with both hearing aids (see table 4) In the speech recognition-
in-noise test, the mean improvement with the standard BAHA as opposed to the 
standard CBHA was -1 7 ± 2 2 dB (t(8) = 2 32, ρ < 0 05) 
These results were compared to those with the individually adapted hearing aids 
(see Experiment I) No significant difference was found in the mean improve­
ment in the MPS or the S/N values A comparison of the individual results 
79 
Chapter 4 
showed that as expected, the results of all the patients with the individually 
adapted hearing aids were equal to or significantly better than those with the 
standard hearing aids 
D I S C U S S I O N 
In Experiment I a comparison was made between individually fitted hearing aids 
worn at the normal daily volume Surprisingly, there was significant improve­
ment in the average aided free field thresholds with the BAHA in the ВС group 
at most frequencies, it is likely that these patients chose a certain volume with 
both hearing aids in order to provide the same aided soundfield threshold A 
relatively higher volume setting for the BAHA than for the CBHA was possible, 
most probably owing to lower distortion levels of the former hearing aid," 
which led to the general improvement in the soundfield thresholds As a conse­
quence, there was a greater closure of the bone gap with the BAHA than with 
the CBHA (Figwe 2) No significant shift in the thresholds was obtained with 
the BAHA compared to the ACHA The difference in thresholds between clinics 
1 and 2 as seen in Figure 1 can be explained by the fact that at clinic 1, 50% of 
the CBHAs were mounted in a spectacle frame and 50% comprised a transducer 
with a body level hearing aid, whereas at clinic 2 these percentages were 82% 
and 18%, respectively 
The majority of patients had similar results with the BAHA and the CHA in the 
speech recognition-in-quiet tests, which is in agreement with previous 
studies 5 6 7 8 l° The MPS improved significantly in 5 patients In the patients with 
a fairly small sensorineural hearing loss component, the MPS obtained with each 
hearing aid reached 100% This ceiling effect made it difficult to differentiate 
between the two hearing aids with this measure At clinic 3, speech recognition 
was measured at conversation level (63 dB SPL) instead of using the speech 
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recognition performance intensity function as applied at clinics 1 and 2 Again, 
it was concluded for this subgroup that the majority of patients had similar 
results with the BAHA and the CHA 
The mean improvement in the speech recognition-in-noise with the BAHA was 
significant in the ВС group but not significant in the AC group As an improve­
ment in the S/N ratio of 1 dB means an improvement in sentence recognition of 
17%,16 the patients in the ВС group showed an average improvement of 39% in 
this respect It should be noted that the S/N ratio does not depend directly on 
the volumesetting of the hearing aid, so the better results with the BAHA cannot 
be ascribed to the overal shift in thresholds As expected, the patients with a 
lower PTAbc had better speech recognition-in-noise results There was no 
significant difference within the four subgroups regarding the improvement in 
the S/N ratio, therefore all the patients benefited to a comparable extent 
irrespective of their sensorineural hearing loss 
Only two patients' performance with the BAHA was significantly worse than 
that with the CHA on one of the speech recognition tests, both patients 
belonged to the AC group The BAHA significantly improved the speech 
recognition of the majority of patients Thirty patients in the ВС group and 6 in 
the AC group improved on at least one test 
In Experiment II nine patients were tested using standard hearing aids Although 
the results with the individually adapted hearing aids were generally better than 
those with the standard hearing aids, the shift in the MPS and the S/N ratio 
found with the individually adapted hearing aids did not change significantly 
when standard hearing aids were used The results from Experiment II are in 
good agreement with those from Experiment I, this means that the improve­
ments found in Experiment I should not be ascribed to better individual fittings, 
but to the hearing aid itself 
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C O N C L U S I O N 
On average there was an improvement in speech recognition with the BAHA 
HC200 in the ВС group in the patients with a PTAbc < 45 dB HL Therefore in 
audiological terms the BAHA is superior to the CBHA No general improve­
ment could be verified in the AC group On an individual level, the speech 
recognition-in-quiet, in noise or in both conditions with the BAHA HC200 
improved in the majority of patients in the ВС group and in half of the patients 
in the AC group 
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I N T R O D U C T I O N 
For some patients with hearing loss, a conventional air conduction hearing aid is 
unsuitable because the auditory canal cannot be occluded or because congenital 
anomalies of the auditory canal or pinna cause fitting problems An alternative 
is to fit a bone conduction hearing aid However, a conventional bone conduc­
tion hearing aid may cause problems for some patients since the transducer must 
be pressed firmly against the skin of the mastoid process which could result in 
skin irritation or headaches Further, for some patients there is inconsistency in 
the quality of speech recognition due to shifting of the transducer or to varying 
pressure against the mastoid Such problems make it annoying or even impossi­
ble to use a conventional bone conduction hearing aid However, the possibility 
of using an implanted bone conduction hearing aid remains 
The Swedish Bone Anchored Hearing Aid (BAHA) avoids the problems of a 
conventional bone conduction hearing aid' because the transducer is connected 
to a percutaneous titanium implant anchored in the temporal bone Patients 
with conductive or mixed hearing loss having pure-tone average bone conduc­
tion (PTAbc) threshold at 0 5 1 and 2 kHz up to 45 dB HL can be fitted with 
the standard ВАНА HC200 ? 1 Another type of commercially available implant­
ed bone conduction hearing aid consists of a magnet implanted in the temporal 
bone driven by an external inductive coil without a percutaneous connection 4 
With this hearing aid, patients with conductive or mixed hearing loss with 
PTAbc up to 25 dB HL can be fitted 
Patients with PTAbc up to 60 dB HL can be fitted with the more powerful 
HC220 The HC220 comprises the HC220 transducer connected to a convention­
al body-level hearing aid It provides more gain and output than the HC200 5 
For patients who are borderline cases for the fitting of a conventional bone 
conduction hearing aid, the HC220 may be successfully applied because of the 
87 
Chapter 5 
higher gain obtained by the direct coupling of the transducer to the skull6 
Furthermore, for patients who use a conventional bone conduction hearing aid 
at high gain settings, the use of a direct bone conduction transducer may enable 
the patient to lower the gain setting and yield a better sound quality 7 
This study reports the results of patients fitted with a HC220 compared with 
either their previous air conduction or conventional bone conduction hearing aid 
Specifically, this study examines the relationship between the magnitude of the 
sensorineural hearing loss component and the results of the speech recognition 
tests as well as the patient's subjective opinion as to which hearing aid they 
preferred Overall, the aim of this study was to evaluate the patients' performance 
with the individually fitted HC220 compared with their individually-fitted 
conventional hearing aid 
PATIENTS 
At two clinics, 26 patients (13 women and 13 men) were fitted with the HC220 
(Table I) The age of the patients varied between 32 and 82 years at the time of 
surgery, with an average of 60 years The patients had been suffering from 
chronic otitis media (25 patients) or chronic otitis externa (1 patient) The pure 
tone average air conduction (PTAac) thresholds at 0 5, 1 and 2 kHz of the ear 
on the implanted side varied from 57 to 108 dB HL and the PTAbc from 33 to 
65 dB HL All of the patients had used a hearing aid in the past The patients 
were divided into two groups on the basis of their previous hearing aid type 
The ВС group had 19 patients who had used a conventional bone conduction 
hearing aid Their average PTAbc was 50 dB HL with a standard deviation 
of 9 dB Fourteen patients had used a bone conduction transducer connected to 
a body-level hearing aid while 5 patients had used hearing spectacles The AC 
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Table 1. Some characteristics of the patient groups from two clinics. The mean 
average air conduction (PTAac) and bone conduction thresholds 
(PTAbc) at 0.5, 1 and 2 kHz are presented. 
Clinic 
1 
2 
η 
18 
8 
AGE 
(yrs) 
57.1 
(32-77) 
66.9 
(44-82) 
PTAac 
(dB HL) 
83.4 
(57-105) 
90.6 
(75-108) 
PTAbc 
(dB HL) 
47.8 
(33-64) 
52.9 
(37-65) 
Previous CHA 
ACHA: 5 
CBHA: 13 
ACHA: 2 
CBHA: 6 
CHA = conventional hearing aid; ACHA = air conduction hearing aid; 
CBHA — conventional hone conduction hearing aid 
group had seven patients who had used an air conduction hearing aid. Their 
average PTAbc was 48 dB HL with a standard deviation of 9 dB. 
The selection criteria for the BAH A used at the two clinics were identical: surgical 
therapy was ruled out, the patient had mixed hearing loss with a PTAac that 
exceeded 30 dB HL at the best ear, and (A) the patient had been using a conventional 
bone conduction hearing aid but experienced inadequate speech recognition (15 out 
of the 19 patients), local pain, skin irritation or headaches (19 out of the 19 patients) 
or serious problems with the appearance of the device (1 patient), or (B) the patient 
had been using an air conduction hearing aid but could not continue to do so as a 
result of chronic otitis media and/or externa that persisted despite medical treat­
ment. 
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METHODS 
The first percutaneous titanium implants were placed in the first half of 1989 The 
surgical technique has been described by Tjellstrom 8 After a recovery period of 
approximately one month, the BAHA HC220 was fitted in combination with a 
conventional body-level hearing aid. After a trial period in which patients compared 
various body-level hearing aids, 13 patients selected a Philips S1594, 7 patients a 
Danavox 107-2PPAGC, 1 patient a Danavox 787PP, 2 patients an Oticon PI IP and 
2 patients an Oticon PI 5P One patient refused to use a body-level aid, so the 
HC220 was connected to an Oticon E39PL behind-the-ear Most of the patients 
had first tried the standard BAHA HC200 but had rejected it because of insufficient 
gain Eight of the 14 patients who had previously used a transducer on a headband 
continued to use the same conventional body-level hearing aid they had used 
before The results for these patients will be described in more detail 
Several audiological tests were performed at least 4 weeks after fitting the 
HC220 Before testing, the hearing aids were checked for normal functioning 
and the hearing aids were adjusted by the patient to a preferred setting. With 
the use of a skull simulator' all HC220s were checked and found to perform 
according to the manufacturers' specification To calculate the unaided PTAbc, 
the best unmasked bone conduction thresholds were used regardless of the ear at 
which they were measured Aided sound-field threshold measurements, phoneme 
recognition-in-quiet and speech recognition-in-noise tests were performed so that 
a comparison between the patients' performance with their individually adapted 
HC220 and their conventional hearing aid could be made. Student's two-tailed 
t-test was applied to analyse differences between results for the HC220 and the 
conventional hearing aids Pearson's correlation coefficients were also calculated 
for some of the audiological data and the degree of sensorineural hearing loss. 
Statistical significance was set at the 0.05 level Finally, the patients filled out a 
questionnaire five months after the HC220 was fitted 
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M A T E R I A L 
All the tests at the two clinics were performed in a double-walled sound-treated 
room The warble tones used to obtain free-field thresholds were generated by a 
standard audiometer (Interacoustics AC-5, ISO 389'°), with a frequency modula­
tion of 5% and were presented by means of a loudspeaker, placed in front of the 
patient The free-field set-up was calibrated according to Stream & Dirks " The 
free-field thresholds were determined twice at 0 25, 0 5. 1,2 and 4 kHz using a 
descending technique with 10 and 5 dB steps 
A speech recognition performance-intensity (PI) function was obtained using the 
free field set-up described above and standard Dutch phonetically balanced word 
lists consisting of ten monosyllables each The PI function was the percentage of 
correctly repeated phonemes as a function of presentation level p Calibration 
was performed as described by Dirks, Stream & Wilson n To start with, the 
phoneme score at 60 dB (comfortable listening level for subjects with normal 
hearing) and 70 dB were obtained If the phoneme score at 70 dB was less than 
100%, phoneme scores at 80 dB and 90 dB were also gathered The maximum 
phoneme score was defined as the highest percentage of correctly repeated 
phonemes To increase reliability, the maximum phoneme score was determined 
twice from two successively determined PI curves The significance of a shift in 
the maximum phoneme score with the HC220 compared with the conventional 
hearing aid was verified using the critical differences for 95% confidence 
intervals when considering the speech recognition score as a binomial variable '4 
To measure speech recognition in noise, the test described by Plomp & 
Mimpen15 was used at Clinic 1 At Clinic 2, no speech recognition-in-noise tests 
were performed In the speech recognition-in-noisetest, lists of thirteen sentences, 
recorded on tape, were used together with a steady state noise signal (65 dB(A)) 
having a spectrum equal to the long-term spectrum of the sentences The speech-
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to-noise ratio was calculated by subtracting the presentation level of noise from 
the presentation level of the speech signal at which 50% of the sentences were 
repeated correctly by the patient The normal value for the speech-to-noise ratio 
is -7 3 dB and the intra-subject standard deviation is 1 dB '5 In this study, the 
difference between two speech-to-noise ratios was regarded as significant if it 
exceeded + 1 4 dB This value was chosen because the speech-to-noise values 
presented were the average values from two successive measurements, hence 
2 χ 1 χ I/V2 = 1 4 dB For some patients, the speech recogmtion-in-noise test 
was loo difficult If the speech-to-noise ratio exceeded +8 dB, the test was 
discontinued 
The questionnaire was derived from a previous study concerning the BAHA16 
and consisted of four questions (1) How many hours did you use the previous 
hearing did and how many hours do you use the HC220 per day9 (2) Which 
hearing aid is better with regard to speech recognition in a quiet environment9 
(3) Which hearing aid is better with regard to speech recognition in a noisy 
environment9 (4) Which hearing aid is better with regard to quality of sound9 
R E S U L T S A N D D I S C U S S I O N 
Ггее-field aided thresholds 
All 26 patients underwent aided free-field threshold measurements Figure 1 
presents the average free-field thresholds for the conventional hearing aids and 
the HC220s Additionally, the speech spectrum area according to Mueller & 
Killion'7 is plotted On average, the ВС group had lower thresholds at all 
frequencies with the HC220 relative to their conventional bone conduction 
hearing aid, whereas the AC group had somewhat lower thresholds for the 
lower frequencies with the HC220 relative to their air conduction hearing aid 
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Figure 1. Aided average free-field thresholds as a function of frequency of the 
group of patients fitted with the conventional bone conduction hear­
ing aid *, with the air conduction hearing aidO and with the BAHA 
HC220 П. The speech area is indicated according to Mueller ά 
Killion'7 
The average improvement in the thresholds for the HC220 over the conventional 
bone conduction hearing aid was significant at 0.5, 2 and 4 kHz (t(18) = 2.2, 2.6 
and 2.5, respectively, ρ < .05). The thresholds with the HC220 were significantly 
better at 0.25 kHz (t(6) = 3.0, ρ < .05) and significantly worse at 4 kHz (t(6) = 
3.0, ρ < .05) compared with their air conduction hearing aid. 
The significant average improvement in the aided thresholds with the HC220 for 
the ВС group, with the hearing aids set at the normal (daily) gain setting, agrees 
with previous studies on the BAHA.2 3 7 '8 The patients use the BAHA at a 
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Table 2. Results on speech recognition tests of 8 patients who were tested with the 
conventional hone conduction hearing aid (CBHA) and with the HC220 
using the same body-level hearing aid. 
MPS (%) S/N ratio (dB) Volume 
Body-level 
hearing aid CBHA HC220 CBHA HC220 CBHA HC220 
Philips S1594 
Danavox 107 
Philips S1594 
Oticon P U P 
Philips S1594 
Oticon P15P 
Philips S1594 
Danavox 787PP 
90 
40 
70 
97 
97 
57 
70 
70 
100s 
63я 
9T 
97 
97 
67 
70 
80 
8.0 
-
2.5 
2.2 
4.6 
-
8.0 
-
3.4s 
-
-0.2s 
0.5s 
-0.2s 
-
5.5s 
-
7 
8 
7 
7.5 
5 
4.5 
7 
8 
6 
5 
4 
5.5 
5 
4.5 
6 
4 
MPS = Maximum Phoneme Score; S/N = Speech-to-noise ratio; s = statistically 
significant improvement at the .05 level. Volume = normal (daily) volumesetting. 
relatively higher gain than the conventional bone conduction hearing aid, most 
probably owing to less sound distortion which facilitates higher output levels 
without reducing sound quality.2 
Table 2 presents the results of the 8 patients for whom only the transducer was 
changed, because they continued to use their former body-level hearing aid. For 
6 patients the gain setting at which the body-level hearing aid was set with the 
HC220 was actually lower than that with the conventional bone conduction 
hearing aid, suggesting a more efficient conversion of electrical energy in bone-
conducted sound vibrations (see also Appendix I). The other results presented in 
Table 2 will be discussed below. 
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100 
MPS (%) 
30 35 40 45 50 55 
PTAbc (dB HL) 
Figure 2a. Maximum phoneme score (MPS) with the HC220 • and the 
conventional bone conduction heaung aid * as a function of the 
average sensorineural hearing loss component at 0 5, 1 and 2 kHz 
(PTAbc) η = 18 A significant worsening m speech recognition 
with the HC220 is indicated mth a black airow a significant 
improvement with a white arrow 
Speech recognition-in-quiet test 
A speech recognition-in-quiet test was completed for 25 patients In Figure 2a 
and 2b the results are presented For the ВС group (Figure 2a), the maximum 
phoneme score for 12 out of 18 patients (one subject was not tested) improved 
with the HC220 from 4% to 33%, in 7 cases this was significant at the 0 05 
level 14 No change was observed for the other 6 patients The average improve­
ment in the maximum phoneme score for the ВС group was 11 6% The 
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improvement in the maximum phoneme score was significantly correlated with 
the PTAbc (n = 15, г = 0 61, ρ < 01) In this latter analysis, 3 patients with 
maximum phoneme score values of 0% or 100% with either hearing aid were 
excluded to avoid floor- and ceiling-effects For the majority of the patients in 
the ВС group, speech recognition-in-quiet improved with the HC220 The degree 
of improvement with the HC220 compared with the conventional bone 
conduction hearing aid increased with the degree of sensorineural hearing loss, 
most probably because of saturation of the output of the conventional bone 
conduction hearing aid was more pronounced than for the bone anchored 
hearing aid 
For the AC group (Figure 2b), the maximum phoneme score improved significant­
ly for 2 patients with the HC220 by 20% and 43% There was no significant change 
for 3 patients, whereas, the maximum phoneme score worsened significantly in 2 
patients by 23% and 40% For the patient with a 40% deterioration, the HC220 
transducer was connected to a behind-the-ear hearing aid This was not an optimal 
arrangement because of its limited output, but unavoidable because a body-level 
hearing aid was refused by this patient In the AC group, the correlation of the 
improvement in the maximum phoneme score with the PTAbc was not significant 
Large differences were observed in the maximum phoneme scores between patients 
(see Figure 2a and 2b) Twelve of the 25 patients had at least one maximum 
phoneme score with the HC220 and/or the conventional hearing aid of 70% or 
below Although it seems obvious that there is a relationship with the PTAbc, for 
some patients with a moderate PTAbc the maximum phoneme score was unexpect­
edly low As all HC220s were found to perform equally on the skull simulator 
(within 3 dB), a possible reason for the disproportionate maximum phoneme scores 
was looked for in the patients Possibly the shape of the audiogram of the patient or 
the presence of neural presbyacusis has played a part In the following analysis, 
high frequency loss was stated to be present if a difference of 30 dB or more was 
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Figure 2b. Maximum phoneme score (MPS) with the HC220 D and the air 
conduction hearing aid 0 as a function oj the average sensorineural 
hearing loss component at 0 5, 1 and 2 kHz (PTAbc) (n = 7) A 
significant worsening in speech recognition with the HC220 is 
indicated with a black arrow, a significant improvement with a white 
arrow 
found between the bone conduction thresholds at 500 Hz and 2000 Hz Further­
more, a relatively large neural involvement was suspected in the hearing loss based 
on the discrepancy between the pure tone bone conduction thresholds and the 
maximum phoneme score according to Gates & Popelka '9 For 5 patients a high 
frequency loss was assumed, for 2 patients (aged 60 and 82 years) a relatively large 
neural involvement was suspected and for 3 patients both were seen (aged 67, 71 
and 72 years). Nine out of these 10 patients had at least one maximum phoneme 
score of below 70% Therefore, the large spread in Figure 2a and 2b may in part be 
the result of the presence of different types of hearing loss among the patients 
Chapter 5 
Speech ι ecognition-in-noise test 
All of the patients at Clinic 1 (n = 18) underwent the speech recognition-in-noise 
test 13 in the the ВС group and 5 in the AC group In Figure 3, the speech-to-
noise ratios with the HC220, conventional bone conduction, and air conduction 
hearing aid are plotted as a function of the PTAbc In the BC gioup, the 
speech-to-noisc ratios of 5 patients exceeded +8 dB for both the HC220 and 
conventional bone conduction hearing aid The test was therefore discontinued 
The speech-to-noise ratio of one of the remaining 8 patients was unchanged with 
the HC220, while it improved in 7 patients The range of improvements in the 
speech-to-noise ratios was -1 1 to -6 0 dB with the HC220 
Application of the 1 4 dB critical difference criterion to the speech-to-noise 
ratios revealed that 6 patients in the ВС group improved significantly with the 
HC220 In the AC group, the speech-to-noise ratios of 3 patients exceeded +8 
dB with both the HC220 and air conduction hearing aid so the test was 
discontinued The speech-to-noise ratio foi one of the remaining 2 patients 
improved significantly with the HC220, while it did not change significantly for 
the other patient The results agree with those from earlier studies that found 
speech recognition-m-noise improvement with the (less powerful!) ВАНА HC200 
in comparison with the conventional bone conduction hearing aid Similarly the 
results of the comparison of the HC200 with the air conduction hearing aid were 
ambiguous 1 1 ъ : о 
Speech lecognition tests in patients in η horn only the tiansduter was changed 
Eight out of 14 patients who had previously used a conventional bone vibrator with 
a conventional body-level hearing aid were fitted with the HC220 transducer with­
out a change in the conventional body-level hearing aid Table 2 presents the results 
for this subgroup of patients The average improvement (+ s d ) in the maximum 
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indicate a significant υηριovement with the HC220 (no significant 
worsering nas found) 
phoneme score was 10 0% ±10 4 (t(7) = 2 7, ρ < 05) and in the speech-to-noise 
ratio, -3 3 ± 1 4 dB (t(4) = 5 2, ρ < 05) Six patients used a lower gain setting when 
fitted with the HC220 (with an average of 1 7 points on the gain control scale of 0 to 
9) Six out of 8 patients improved significantly on one or both speech recognition 
tests Therefore, because the body-level hearing aid is not changed, the improve­
ments seen with the HC220 compared to the conventional bone conduction 
vibrator most probably result from the lower gain setting leading to a better 
performance of the amplifier The lower gain setting results from the more efficient 
stimulation via the bone anchored implant (see also Appendix I) 
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Table За. Results of the questionnaire of the ВС group (n = 19). Which 
hearing aid is better with regard to ....? 
Question CBHA HC220 no difference 
Speech recognition in a quiet environment 4 12 3 
Speech recognition in a noisy environment 4 9 6 
Quality of soun 1 13 5 
CBHA = conventional bone conduction hearing aid 
Questionnaire 
All 19 patients of the ВС group had used their previous bone conduction hear­
ing aid as well as their HC220 for more than 8 hours per day. All but one of the 
7 patients of the AC group had used their previous air conduction hearing aid 
for more than 8 hours per day. One patient did not use it at all, due to instantly 
recurring otorrhoea with the use of earmolds. Five patients of the AC group 
used their HC220 for more than 8 hours per day and 2 patients used it for less 
than 2 hours due to insufficient gain. One of the latter 2 patients was the one 
fitted with the HC220 in combination with the behind-the-ear hearing aid. 
The results of the questions on speech recogniton in a noisy environment, in a 
quiet environment, and the quality of sound are presented in Table 3a and 3b. 
In the ВС group (Table 3a), the HC220 is preferred more often than the 
conventional bone conduction hearing aid. Two of the patients of the AC group 
(Table 3b) preferred the air conduction hearing aid on all 3 aspects. One of 
these two patients used the HC220 in combination with the behind-the-ear 
hearing aid. Both of these patients had significantly worse maximum phoneme 
scores with the HC220 compared with their air conduction hearing aid. 
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Table 3 b. Results of the questionnaire of the AC group (n - 7). Which hearing aid 
is better with regard to ....? 
Question ACHA HC220 no difference 
Speech recognition in a quiet environment 3 3 1 
Speech recognition in a noisy environment 2 5 0 
Quality of sound 3 3 1 
ACHA - air conduction hearing aid 
Altogether, 6 patients (23%) preferred their previous hearing aid in terms of 
speech recognition. The results of the questionnaire corresponded with the audi-
ologic results. 
CONCLUSION 
The audiological results with the HC220 were on average better than those with 
the conventional bone conduction hearing aid. For patients who did not change 
the body-level hearing aid, it was demonstrated that these results were obtained 
at lower volume control settings. Of the patients who had previously used an air 
conduction hearing aid, some experienced improvement while others experienced 
deterioriation in performance with the HC220. Nevertheless, for these patients 
the HC220 is still the best choice because they no longer can use the air 
conduction hearing aid, and performance is poorer with the conventional bone 
conduction hearing aid. 
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I N T R O D U C T I O N 
For conventional bone conduction hearing aids, the sound signal which is 
produced by a transducer pressed against the mastoid process, is transmitted 
transcutaneously to the skull Nowadays, a new bone conduction hearing aid is 
available, which makes use of a transducer attached to a percutaneous coupling 
This device is called the Bone Anchored Hearing Aid (BAHA) ' : 14 One of the 
advantages of the BAHA is that there is no longer any atténuation of the sound 
signal by the skin and subcutaneous layer 
The degree of "improvement" in the bone conduction thresholds proved to differ 
between patients, ι e the conventional bone conduction thresholds obtained 
transcutaneously (called the tbc thresholds) minus the bone conduction thresh­
olds obtained percutaneously (called the ptc thresholds) It has been argued that 
this might be directly related to attenuation5 and therefore to the thickness of 
the skin and subcutaneous tissue layers 6 If the thickness of the skin and 
subcutaneous tissue, and the improvement in bone conduction thresholds (tbc-
pbc thresholds) are related, the thickness measured pre-operatively might be a 
useful indicator of the degree of improvement which can be expected and 
consequently act as an indicator of whether the fitting of the BAHA will be 
successful Such an indicator could then be applied to potential BAHA patients 
with bone conduction thresholds near to or just exceeding the criterion 
concerning the maximum average sensorineural hearing loss component of 60 dB 
HL for the successful application of a BAHA : 4 
At the ENT Department of the University Hospital Nijmegen, conventional 
transcutaneous bone conduction (tbc) thresholds and percutaneous bone conduc­
tion (pbc) thresholds were obtained as part of the evaluation procedure for 
patients fitted with the BAHA and the degree of "improvement" was calculated as 
a function of frequency (the tbc-pbc thresholds) In addition, it was investigated 
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whether the thickness of the skin and subcutaneous tissue had any influence on 
the improvement in the patient's performance between the former hearing aid 
and the BAHA This was accomplished by correlating the improvement (or 
worsening) in two speech recognition scores (which were independent of the 
volume setting of the hearing aids) with the thickness measurement 
M A T E R I A L AND M E T H O D S 
Patients 
Our study group comprised 57 patients who were fitted with a BAHA, 29 were 
female and 28 were male Their age varied from 10 to 76 years with a mean of 
46 years The average hearing loss at 0 5, 1 and 2 kHz varied from 30 to 105 dB 
HL with a mean of 64 dB HL All the patients had previously used cither a 
conventional bone conduction hearing aid (n=46) or an air conduction hearing 
aid (n=ll) From previous studies on these patients, two speech recognition 
scores (speech recognition in quiet and in noise) were available, both had been 
obtained twice, once with the previous conventional hearing aid and once with 
the BAHA 7ä The relation between the thickness of the skin and subcutaneous 
tissue and the change in these speech recognition scores was studied 
Methods 
The thickness of the skin and subcutaneous tissue was measured at the 
contralateral side to the implant, at the same location as the implantation site A 
thin sterilised needle with mm marks was used for this purpose The needle was 
inserted until the skull was reached Anaesthesia was not used The measurement 
was repeated three times at different locations, over an area of 2 cm1 and an 
average value was calculated The measurement error was estimated from repeated 
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measurements and amounted to 0 5 mm Hearing thresholds were determined 
using standard procedures and equipment (Interacoustics AC-5 audiometer, 
calibrated according to ISO 3899) The bone conduction thresholds on the 
implanted side were obtained twice Fnstly, they were obtained with the standard 
transducer B-71 (Radioear) placed against the mastoid process, according to 
Dirks,10 without touching the implant In this way, the tbc thresholds were 
obtained Subsequently the pbc thresholds were determined using the special 
transducer HC240 (Nobelpharma Ine ") coupled to the implant "" Non-masked 
thresholds were compared because in the present study, it was not important in 
which ear the hearing sensations occurred Thresholds were obtained at the 
octave frequencies from 250 to 4000 Hz If the threshold at a given frequency 
exceeded the limits of the audiometer with either of the transducers the result at 
that frequency was not used in the analysis 
The electrical input of the transducers at the hearing thresholds was determined 
by measuring the current driving the transducer The difference in potential 
across a specially applied series resistance of 0 5 Ohm was measured with a 
Fluke 8840A measuring device As a result, the tbc-pbc thresholds were 
expressed in dBcu (dB current level, reference 1 μΑ) The advantage of expressing 
the thresholds in dBcu is that it is independent of special calibration devices On 
the other hand, the (mechanical) output of the transducers is not necessarily 
reflected at the (electrical) input side ' 5 But, as there is no single calibration device 
suitable for calibrating the output of both the B71 and the HC240 transducers, 
the expression in dBcu is preferred The linearity of both transducers was 
checked by measuring input-output functions at the frequencies 0 25, 0 5, 1,2 
and 4 kHz The B71 transducer connected to the audiometer was coupled to the 
Bruel and Kjear 4930 artificial mastoid The B71 transducer was linear up to the 
maximum level of the audiometer for bone conduction The HC240 connected to 
the audiometer was coupled to the skull simulator TU 1000 (Nobelpharma 
Ine ") Again, linear behaviour was observed up to the maximum level of the 
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audiometer for bone conduction From previous studies on these patients, two 
speech recognition scores were available, both had been obtained twice, once 
with the previous conventional hearing aid and once with the BAHA The 
maximum phoneme score (the speech recognition-in-quiet score) was derived 
from the free-field speech performance-intensity function or the speech 
audiogram (depicting the percentage of correctly repeated phonemes as a 
function of the presentation levels12) and the speech recognition-in-noise score 
was obtained from the speech-in-noise test, according to Plomp & Mimpen '3 
Detailed information on these speech recognition measures are presented 
elsewhere 7 8 The relation between the thickness of the skin and subcutaneous 
tissue and the change in speech recognition scores is only of interest in the 
patients who previously used a bone conduction hearing aid (n - 46), so the 
results of the patients who previously used air conduction hearing aids were not 
used in this part of the study 
R E S U L T S 
The thickness of the skin and subcutaneous tissue varied from 1 to 13 mm with 
a mean of 6 0 mm and a standard deviation of 2 3 mm In Figure 1, the tbc-pbc 
thresholds averaged at 0 5, 1 and 2 kHz (the so-called PTAtbc-PTApbc) are 
plotted as a function of the thickness of the skin and subcutaneous tissue A 
poor, non-significant correlation was found (r = -0 19, η = 52) Correlation 
analysis was performed for the separate frequencies (250 to 4000 Hz) The 
correlation coefficients between the thickness and the tbc-pbc thresholds ranged 
from 0 09 (n = 56) at 500 Hz to -0 29 (n = 43) at 4000 Hz, but were not 
statistically significant (tested at the 5% level) Therefore, there was no 
correlation between the thickness of the skin and subcutaneous tissue, and the 
improvement in bone conduction thresholds owing to percutaneous stimulation 
instead of transcutaneous stimulation 
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PTAtbc - PTApbc (dB, ref 1 microA) 
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Figure 1. The average transcutaneous bone conduction of all the patients at 
0 5,1 and 2 kHz (PTAbc) minus the average percutaneous bone 
conduction threshold at the same frequencies (PTAbc) plotted as a 
junction of the thickness of the skin and subcutaneous tissue layers 
The correlation coefficients between the thickness of the skin and the subcuta­
neous tissue, and the change in the maximum phoneme score and the speech-to-
noise ratio (obtained with the previous conventional bone conduction hearing 
aid and the BAHA) amounted to -0 10 and 0 03, respectively Again, these 
correlation coefficients were not statistically significant (tested at the 5% level) 
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D I S C U S S I O N 
Hâkansson et dl ' 5 showed that there is substantial attenuation of acoustical 
vibrations by the skin and subcutaneous tissue layers in the mastoid region, in the 
order of 10 to 20 dB Generally, the damping of an acoustical wave by a layer 
of a certain material depends, amongst others, on the thickness of the layer 
Surprisingly, the present study showed that the thickness of the skin and 
subcutaneous tissue layers was not related to the improvement in bone 
conduction thresholds or to the change in two speech recognition scores when 
the previous (transcutaneous) bone-conduction hearing aid was compared to the 
BAHA It should be noted that the thickness of the skin and subcutaneous 
tissue in the majority of patients was between 4 and 8 mm. ι e a rather limited 
span of 4 mm Extremes of less than 4 mm or over 8 mm were infrequent, which 
could have influenced the results 
The tbc-pbc values were expressed in dB current level measured at the input side 
of the tiansducers (see Method section) These values would probably have been 
different expressed as an output measure (e g force) As both the B71 and 
HC240 transducers displayed linear behaviour, the use of an output measure 
would have led to a shift in the tbc-pbc values but of equal size lor all the 
patients Therefore, this would not have influenced the present correlation 
coefficients The non-significant correlations between the thickness of the skin 
and tissue layers and the audiological measures remains unexplained Various 
properties may play a part, e g the thickness of the different sublayers, their 
actual state under static pressure (the B71 transducer has to be applied with a 
static force of about 5 5 N) and their damping properties The present set-up 
does not allow us to explain the results in any more detail but we can draw the 
clinically relevant conclusion that the thickness of the skin and subcutaneous 
tissue determined pre-operatively cannot be used as an extra indicator of whether 
the application of a BAHA will be successful in patients with bone conduction 
thresholds near to or just exceeding the criterion for fitting a BAHA 
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I N T R O D U C T I O N 
Hearing did performance in patients can be assessed using audiological tests 
However, the audiological test results and the patients' own opinion on a hear-
ing aid may not necessarily agree, therefore an evaluation of the patients' 
opinion on the hearing aid should be considered This study presents the 
subjective results of the Bone Anchored Hearing Aid (BAHA) compared to a 
conventional hearing aid obtained with the use of questionnaires 
The BAHA comprises a transducer coupled to a percutaneous implant placed in 
the temporal bone and thus establishes constant and direct transmission of 
sound It was developed in Goteborg, Sweden ' 2 3 This system of direct bone 
conduction is fitted in patients who require a hearing aid, but for whom a 
conventional hearing aid (an air conduction hearing aid(ACHA)or a conventional 
bone conduction hearing aid (CBHA)) proved to be unsuitable For example, 
blockage of the auditory canal by the earmould can lead to persistent otorrhoea, 
and a congenital malformation of the pinna or auditory canal makes it 
impossible to fit an air conduction hearing aid A conventional bone conduction 
hearing aid (CBHA) may also cause serious problems in a number of patients, 
because the transducer is pressed against the skin of the temporal bone with 
considerable force Therefore, skin irritation and pain may occur 
The audiological results with the BAHA in comparison with the conventional 
bone conduction hearing aid were good, which demonstrated an improvement in 
speech recognition 234 In comparison with the air conduction hearing aid, the 
results were ambiguous14 Several studies on the comparison of the BAHA with 
the conventional hearing aid included subjective results obtained by a question-
naire Questions mostly concerned hearing, sound quality, whether it was 
comfortable to wear, cosmetic appearance, practical arrangement and utilization 
time In order to make a comparison after fitting the BAHA, most studies asked 
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the patients whether the BAHA was better, equal or worse than their previous 
conventional hearing aid in a specified situation,1 λ or the patients were asked to 
describe the advantages and disadvantages of the BAHA via open-ended ques­
tions 5 A third type of questionnaire compared hearing aids using questions with 
answers on a numerical scale, preferably administered at the time the specific 
hearing aid was being used 6 For all types of questionnaire, a prerogative to 
reduce "enthusiasm" bias and to overcome fitting problems in the comparison 
between an old and a new hearing aid, is that the patient has to have been using 
the new hearing aid for a sufficient period of time All the studies reported a 
general preference for the BAHA compared to the conventional bone 
conduction hearing aid 
In this study, the results with the BAHA were compared to those with the 
previous hearing aid by means of two types of questionnaire The results with 
the BAHA in patients who had previously used a conventional bone conduction 
hearing aid and those who had previously used an air conduction hearing aid 
are presented separately The results of the questionnaires are discussed in 
relation to the audiological results which have been presented elsewhere 4 7 8 
P A T I E N T S 
Questionnaires A and В were completed by the first 65 patients who were fitted 
with the BAHA at our clinic and had been using it for at least 5 months The 
selection criteria for the BAHA have been presented elsewhere 4 7 8 A 66lh patient 
of this consecutive sample was undergoing treatment with an anticoagulant drug 
following a heart attack a few days after the placement of the implant under 
general anaesthesia As a result, a large haematoma formed under the autolo­
gous skin transplant After the application of a pressure dressing, recovery was 
good However, the patient complained about severe pain around the titanium 
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Table 1. Characteristics of 65 patients, divided in two groups according to their 
previous hearing aid. 
Group 
ВС 
AC 
η 
49 
16 
Age 
(years) 
46 
(10-76) 
49 
(26-77) 
PTAac 
(dB HL) 
62 
(30-105) 
72 
(40-100) 
PTAbc 
(dB HL) 
25 
(1-64) 
31 
(8-63) 
ВС group, AC group = groups of patients who previously used a conventional bone 
conductor or an air conduction hearing aid respectively; η = number of patients; 
PTAac, PTAbc = average air conduction (ac) and bone conduction (be) thresh­
olds at 0.5, 1 and 2 kHz; the range is given between brackets 
implant throughout the follow-up of 8 months. As a result the BAHA was not 
fitted and the patients' results were not included in this study. 
The patients were divided into two subgroups according to their previous hear­
ing aid: either a conventional bone conduction hearing aid (ВС group compris­
ing 49 patients), or an air conduction hearing aid (AC group comprising 16 
patients). Characteristics of the patients in these two subgroups are presented in 
Table 1. The patients were fitted monaurally with the ВАНА HC200 (36 
patients in the ВС group and 11 in the AC group) or the more powerful "super-
bass" ВАНА HC220 (13 patients in the ВС group and 5 in the AC group) 
depending on their sensorineural hearing loss components. 
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M A T E R I A L S AND M E T H O D S 
In 1988, implantation of percutaneous implants for the BAHA was started in 
Nijmegen The institutional ethics review committee approved the project and 
informed consent was obtained from all the patients after the nature of the 
procedure had been explained to them All expenses of the project, including the 
purchase of the BAHA for the patients, were covered by the grants 
Two questionnaires were used (see Appendix II) Questionnaire A was derived from 
a previous study on the BAHA5 and consisted of five questions The questions were 
posed such that the patient could make a comparison between his/her previous 
hearing aid and the BAHA Question 5 on speech recognition in noise was added to 
Questionnaire A merely as a measure to evaluate whether the patients gave consis­
tent answers the results were compared to those in Questionnaire В on speech 
recognition in noise Questionnaire В consisted of questions which were to be 
answered on a scale of 1 to 10, score 1 represented the most negative answer 
(extremely poor) and score 10 the most positive answer (excellent) This 
questionnaire (see Appendix II) was derived from a previous study on hearing aids 9 
The questions were divided into four different categories representing speech 
recognition in quiet (Quiet, 5 questions), speech recognition in noise (Noise, 9 
questions), quality of sound (Quality, 11 questions) and whether it was comfortable 
to wear (Comfort, 5 questions) 
Questionnaire A was filled out 5 months after the BAHA was fitted to minimize 
the influence of "enthusiasm" bias on the one hand and fitting problems on the 
other Questionnaire В was filled out for the first time concerning the conven­
tional hearing aid prior to the implantation of the percutaneous implant It was 
filled out for the second time concerning the new hearing aid after the BAHA 
had been used for 5 months The scores from the first session, concerning the 
conventional hearing aid, were made available to the patient during the second 
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session Subsequently, the average score for the conventional hearing aid and the 
BAHA per category (Quiet, Noise, Quality, Comfort) were calculated and 
subtracted which gave rise to difference scores (AQuiet, ANoise, AQuahty and 
AComfort) 
The differences in the subjective scores on Questionnaire В and the differences in 
the audiological (speech recognition) scores were correlated For this purpose, 
two speech recognition scores were available the maximum phoneme score 
which was derived from the speech recognition-in-quiet performance-intensity 
function (depicting the percentage of correctly repealed phonemes as a function 
of the presentation levels10) and the speech-to-noise ratio which was obtained 
from the speech recogmtion-in-noise test according to Plomp & Mimpen " 
Detailed information on the maximum phoneme scores and speech-to-noise 
ratios of the present patient group have been published elsewhere 4 8 Differences 
in the results of the Questionnaires between the patients fitted with the BAHA 
HC200 and the patients fitted with the BAHA HC220 are discussed 
R E S U L T S 
Questionnaire A 
The daily utilization time of the BAHA and the previous hearing aid were fairly 
similar (Question 1) Of the 49 patients who had previously used a bone conduc­
tor (ВС group), 44 patients (90%) had used their bone conductor more than 8 
hours per day, 4 patients (8%) for between 2 and 8 hours and 1 patient (2%) for 
less than 2 hours per day After being fitted with the BAHA (HC200 or HC220) 
all 49 patients used the BAHA for more than 8 hours per day Of the 16 
patients who had previously used an air conduction hearing aid (AC group), 15 
patients (94%) had used the air conduction hearing aid more than 8 hours per 
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day and 1 patient (6%) had not used it at all as a result of recurrent otorrhoea 
Aflei being fitted with the BAH A 15 (94%) of these patients used the BAHA for 
more than 8 hours and 1 patient used it for between 2 and 8 hours per day 
(6%). The latter patient had been suffering from pain around the implant since 
implantation, for which no explanation could be found As the pain showed a 
steady decrease, the patient was able to gradually lengthen the utilization time, 
from 4 hours immediately after being fitted with the BAHA to almost 8 hours 
after 5 months 
The results of Question 2 which concerned the patients' preference for a hearing 
aid on the basis of various heanng-aid-related aspects, are presented in Figure 
la and lb. The results of Questions 3 and 4 which attached a certain degree of 
importance to the results of Question 2, are presented in Table 2a and 2b In the 
ВС group (Figwe la), the patients preferred the BAHA to the conventional 
bone conduction hearing aid on all the aspects The improvement in speech 
recognition was regarded as the greatest advantage or the second most impor­
tant advantage of the BAHA by most of the patients (Table 2a), the improve­
ment in sound quality was also given as an important second advantage Many 
of the patients in the ВС group did not fill out Question 4 regarding the greatest 
disadvantage (27 patients (55%)) and the second most important disadvantage 
(40 patients (82%)) of the BAHA However, a proportion of those who did, 
designated the visabihty as an important disadvantage (Table 2a) 
Figure la presents the combined results of the patients who were using the 
BAHA HC200 and the BAHA HC220 In general, similar results were seen for 
the patients who were fitted with these types of BAHA However, there was no 
clear difference between the visabihty and handling of the BAHA HC220 and 
the conventional bone conduction hearing aid, most probably because the 
BAHA HC220 is combined with a body-level hearing aid 
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N patients % patients 
40 
30 
20 
10 
ear speech sound visability skin handling 
infection recognition quality irritation 
Ш CBHA better • BAHA better 
100% 
80% 
60% 
40% 
20% 
0% 
Figure la. Results of Questionnant' A. question 2 which concerned the patients' 
preference jor the BAHA οι the conventional healing aid Numbei 
and percentage oj patients who pieviously used a conventional hone 
conduction hearing aid (n - 49) that favoured the conventional hone 
conduction hearing aid οι the BAHA with lespeet to various 
hearmg-aid-related aspects The number erf patients that e\pei lenced 
no diffei enee are not depic ted 
In the AC group, the patients favoured the BAHA with regard to the occurrence 
of ear infections and skin irritation, and Ihcre was a slight preference for the 
BAHA with respect to speech recognition and sound quality (Figwe lb) 
According to 11 out of the 16 patients in the AC group, the reduction in the 
occurrence of ear infections was the greatest advantage of the BAHA (Table 2b) 
Better speech recognition was mentioned most frequently as the second most îm-
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N patients % patients 
100% 
80% 
60% 
40% 
20% 
ear speech sound visabihty skin handling 
infection recognition quality irritation 
ACHA better • BAHA better 
Figure lb. Remits of Questionnai!e A question 2 which concerned the patients' 
preference foi the BAHA οι the comentional heating aid Numbet 
and percentage of patients и ho previously used an an conduction 
hearing aid (n = 16) that favoured the air conduction hearing aid or 
the BAHA with respect to vanous heatmg-aid-ielated aspects The 
number of patients that experienced no dijfetence aie not depicted 
portant advantage The question about the greatest disadvantage was answered 
by 8 out of the 16 patients in the AC group Four of them mentioned worse 
speech recognition with the BAHA On average, no difference was seen between 
the results of the patients fitted with a BAHA HC200 and BAHA HC220, 
except that more of the patients preferred the BAHA HC 200 to the air conduction 
hearing aid with regard to visabihty This changed when a body-level hearing 
aid was needed more of the patients favoured the air conduction hearing aid to 
the BAHA HC220 with regard to visabihty and handling 
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Table 2a. Results of Questionnaire A, questions 3 and 4 which concerned the 
importance of the various hearing-aid-related aspects for the patient. 
Number of patients who previously used a bone conduction hearing aid 
(n = 49) that regarded a certain aspect as the greatest advantage, the 
second most important advantage, the greatest disadvantage or the 
second most important disadvantage of the BAH A compared to the 
conventional bone conduction hearing aid. The number of patients that 
did not answer the question are not depicted. 
Hearing-aid 
related aspect 
ear infections 
speech recognition 
sound quality 
visability 
skin irritation 
handling 
Advantage 
first 
6 
24 
9 
5 
4 
1 
second 
5 
15 
13 
3 
5 
8 
Disadvantage 
first 
_ 
2 
2 
8 
4 
6 
second 
_ 
2 
2 
2 
3 
-
Questionnaire В 
The mean differences (Δ) between the scores with the BAH A and the conventional 
hearing aid on the four question categories Quiet, Noise, Quality and Comfort are 
presented in Table 3. Positive values were seen which means that on average, more 
of the patients in the ВС group preferred the BAH A. The significance of the Δ 
values was tested with the t-test (AQuiet (t(40) = 6.8, ρ < .01), ANoise (t(48) = 7.8, 
ρ < .01), AQuality (t(48) = 5.9, ρ < .01) and AComfort (t(48) = 7.4, ρ < .01). There 
was no significant difference between the results of the patients in the ВС group 
who were fitted with the ВАНА HC200 or the ВАНА HC220. 
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Table 2b. Results of Questionnaire A questions 3 and 4 which concerned the 
importance of\anous hearmg-aid-ielated aspects for the patient 
Numbei of patients who previously used an air conduction healing aid 
(n - 16) that regarded a сенат aspect as the greatest advantage the 
second most important advantage, the gieatest disadvantage or the 
second most important disadvantage of the BAHA compaied to the 
conventional hearing aid The numbei oj patients that did not answer 
the question aie not depicted 
Heann-aid 
related aspect 
ear infections 
speech recognition 
sound quality 
visabihty 
skin irritation 
handling 
Advantage 
first 
11 
3 
-
1 
1 
-
second 
1 
5 
3 
1 
4 
1 
Disadvantage 
first 
_. 
4 
1 
3 
-
-
second 
. 
-
1 
1 
-
1 
In the AC group, the mean differences were not significantly different from zeio 
(t-test at the 5% level) However for the small subgroup of patients in the AC 
group who were fitted with the BAHA HC220 (n=5), the values AQuiet (t(4) = 
3 2, ρ < 05), ANoise (t(4) = 3 7, ρ < 05) and AQuahty (t(4) = 3 0, ρ < 05) were 
found to be significant In the subgroup of patients fitted with the BAHA 
HC200, on average, no significant difference scores were found 
Question 5 of Questionnaire A which concerned speech recognition in noise (see 
Appendix II) was used merely to check the consistency of the answers of the 
patients The results of question 5 of Questionnaire A (converted to a scale of 1 
to 5) were compared to the results of question 2 of Questionnaire В (ANoise 
value) which also concerned speech recognition in noise A significant correlation 
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Table 3. Results of the four categories of Questionnaire В (Quiet, Noise, Quality, 
Comfort); difference scores (A) are given (BAHA scores minus 
conventional hearing aid scores). 
η AQuiet ANoise AQuality AComfort 
ВС 49 1.6(1.5) 2.0(1.8) 1.6(1.9) 1.7(1.6) 
AC 16 0.8(2.2) 1.0(2.2) 0.8(2.2) 0.2(2.6) 
ВС group, AC group = groups of patients who previously used a conventional bone 
conductor or an air conduction hearing aid respectively; η - number of patients; 
the standard deviation is given between brackets 
was found between the answers to both questions (Spearman rank coefficient = 
0.52, ρ < .01). 
The question on cleaning the skin around the implant revealed that 5 (8%) out 
of the 65 patients often had difficulty with taking care of the implant and 
surrounding skin, 15 (23%) sometimes and 45 (69%) never had any difficulty. 
Comparison between the audiological data and the questionnaire results 
All 65 patients underwent the audiological speech recognition-in-noise test. A 
speech-to-noise ratio was obtained for 55 of these 65 patients, for the remaining 
10 patients the test was too difficult.4,8 According to questionnaire B, 34 out of 
the 55 patients preferred the BAHA with respect to speech recognition in noisy 
surroundings, 6 patients preferred their previous hearing aid and 15 patients had 
no preference. The average improvement of the speech-to-noise ratio of the 
group of patients who preferred the BAHA was better than that of the group of 
patients who preferred the previous hearing aid: -2.5 ± 2.2 dB versus -0.5 ± 2.2 
dB respectively (t(38) = 2.05, ρ < .05). 
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As a result of ceiling effects, several patients obtained a maximum phoneme 
score of 100% with the conventional hearing aid and with the BAHA 4 These 
patients were excluded from the subsequent analysis. According to questionnaire 
B, 32 out of the remaining 44 patients preferred the BAHA with regard to 
speech recognition in quiet surroundings, whereas 5 patients preferred the 
former hearing aid The average improvement in the maximum phoneme score 
for both subgroups was 9% ± 11% and 4% ± 11%, respectively (ns) 
From binaural to monaural amplification 
Seventeen out of the 65 patients had previously used a conventional hearing aid 
binaurally, 3 had used an air conduction hearing aid and 14 a conventional bone 
conduction hearing aid Thirteen patients of the ВС group answered the question 
on directional hearing Six of them (46%) reported that the conventional bone 
conduction hearing aid fitted binaurally was better with regard to 
directional hearing, 5 (39%) preferred the BAHA fitted monaurally and 2 
patients (15%) did not experience any difference (Questionnaire B, additional 
question) 
The AQuiet and ANoise scores did not differ significantly between the patients 
who had previously used a conventional hearing aid binaurally and the patients 
who had used a conventional hearing aid monaurally (Table 4) 
C O M M E N T 
BAHA compared to a conventional bone conduction hearing aid 
The results of Questionnaire A showed that the BAHA was considered to be 
better than the conventional bone conduction hearing aid with regard to speech 
recognition, quality of sound and skin irritation (Figwe la) Only the patients 
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Table 4. Results of two categories of Questionnaire В (Quiet and Noise scores) 
for patients who were fitted with the previous hearing aid binaurally or 
monaurally; difference scores Δ are given (BAHA scores minus 
conventional hearing aid scores) 
ВС group AC group 
Binaural Monaural Binaural Monaural 
(n = 14) (n = 35) (n = 3) (n = 13) 
AQuiet 3.3(3.0) 2.9(3.6) 0.1(0.2) 1.0(2.4) 
ANoise 2.3(1.8) 1.8(1.8) -0.5(0.9) 1.4(2.2) 
ВС group, AC group - groups of patients who previously used a conventional bone 
conductor or an air conduction hearing aid, respectively; η - number of patients; 
Quiet = speech recognition in quiet; Noise - speech recognition in noise; the 
standard deviation is given between brackets 
who were fitted with the ВАНА HC200 preferred the BAHA to the 
conventional bone conduction hearing aid with regard to the visability. The 
results of Questionnaire В also showed that an on average there was significant 
improvement in the scores with the BAHA compared to the conventional bone 
conduction hearing aid for the four categories: speech recognition in quiet and 
speech recognition in noise, quality of sound and comfort. This significant 
improvement in speech recognition in quiet and in noise with the BAHA on 
Questionnaire B, was in good agreement with the significant improvement in the 
audiological results for the speech recognition in quiet and in noise scores 
presented elsewhere.48 Only minor differences were seen between the results of 
patients with a BAHA HC200 (patients with a mild to moderate sensorineural 
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hearing loss component) and those with a BAHA HC220 (patients with a more 
severe sensorineural hearing loss component) Therefore, the overall satisfaction 
with the change from the bone conduction hearing aid to the BAHA did not 
seem to depend on the magnitude of the sensorineural hearing loss component 
BAHA compaied to an an conduction hearing aid 
The patients fitted with the BAHA HC200 who had previously used an air 
conduction hearing aid only improved clearly with regard to the occurrence of ear 
infections and skin irritation Speech recognition and the sound quality with the 
BAHA were reported to be better than with the air conduction hearing aid by more 
than half of the patients (Figuie lb) Only the 5 patients who were fitted with the 
BAHA HC220 in this subgroup rated speech recognition significantly better with 
the BAHA than with the air conduction hearing aid The non-significant differences 
in the scores for the AC group as a whole (Table 3) were in agreement with the 
ambiguous audiological results with the BAHA compared to the air conduction 
hearing aid 
For the total patient group it was found that the answers given were sufficiently 
consistent, as a significant correlation was found between the answers given to 
the two questions (one question in each questionnaire) on speech recognition in 
noise 
Comparison with the results reported m hteratwe 
These results are in general agreement with literature which concern subjective 
results of the BAHA HC200 only Two large studies (Tjellslrom et al,5 η = 62, 
Hákansson et al,3 η = 146) using questionnaires, reported an improvement of 
speech recognition with the BAHA compared to previous hearing aids but with­
out regarding the patients who previously used an air conduction hearing aid or 
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a conventional bone conduction hearing aid separately Two smaller studies 
(Lindeman & Tengstrand,'1 η = 8, Bonding et al,11 η = 12) reported a statistical­
ly significant improvement in questionnaire results with the BAHA compared to 
the conventional bone conduction hearing aid which was not reflected by the 
results on the speech discrimination tests 
For those patients in the present group who felt that they had improved speech 
recognition in noise with the BAHA compared to with a conventional bone 
conduction hearing aid or with an air conduction hearing aid, on average the speech 
recognition-in-noise test scores were better than the patients who did not expenence 
an improvement Therefore, this part of the study leads to the conclusion that there 
was fair agreement between the questionnaire and the speech recognition tests 
The patient group that had previously used a conventional hearing aid binaurally 
did not have different subjective results for speech recognition with the BAHA 
fitted monaurally compared to the patient group that had previously used a 
conventional hearing aid monaurally (Table 4) In the group of patients that had 
used a conventional bone conduction hearing aid binaurally, as many patients 
favoured the binaural conventional hearing aid as the BAHA with regard to 
directional hearing This surprising result can most probably be explained by the 
fact that directional hearing was not optimal with a conventional bone conduction 
hearing aid fitted binaurally as a result of the immediate transcranial transmission 
of sound in the skull 
In conclusion, the patients found the BAHA to be a good alternative for the 
conventional bone conduction hearing aid These subjective results were in 
agreement with the audiological results presented elsewhere4" In view of these 
results, the BAHA could become the first choice in bone conduction hearing 
aids However, disadvantages of the BAHA are that an operation is needed, the 
percutaneous implant needs special care and the BAHA is more expensive than 
a conventional bone conduction hearing aid It should be noted that for patients 
129 
Chapter 7 
with dn dir conduction hearing aid, the BAHA was fitted because of recurrent 
ear infections and because a trial period with a conventional bone conduction 
hearing aid had not been a success The fact that the air conduction hearing aid 
was considered to be better by some of these patients and the audiological 
results with the air conduction hearing aid were also bettei in some of them,4!< 
does not mean that the BAHA is unsuitable in such cases, but it does mean that 
the patients should be well-informed beforehand about the possibility of 
obtaining poorer results for speech recognition than those they were accustomed 
to With the knowledge of the advantages and disadvantages of the BAHA 
mentioned above, the BAHA is a good alternative for the conventional bone 
conduction hearing aid if a patient can no longer use an air conduction hearing 
aid 
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S U M M A R Y AND C O N C L U S I O N S 
In this thesis the results are discussed of a prospective clinical study on the 
application of a new type of bone conduction hearing aid Using conventional 
bone conduction hearing aids, sound vibrations are transmitted to the skull via a 
transducer piessed firmly against the vault of the skull With the percutaneous 
system described in this thesis, the skin is permanently penetrated by a titanium 
implant anchored in the temporal bone A special bone conduction hearing aid 
called the Bone Anchored Hearing Aid (BAHA) can be attached to the percuta-
neous implant The skin penetrated by the implant is an autologous transplant 
obtained from a non-hairbeanng region which is thoroughly thinned The 
periosteum at the implant site is removed and the subcutaneous tissue of the 
surrounding skin is reduced extensively to restrict movement of the skin in 
relation to the implant 
Although a number of histological, audiological and clinical experimental studies 
on the BAHA system have been performed in Sweden,n 1 4 5 6 7 additional 
prospective studies from other centres were needed It is of importance to know 
whether the good results obtained in Goteborg could be reproduced elsewhere 
Knowledge on the extent to which hearing and speech recognition could be 
improved with the BAHA in standardised circumstances needed broadening 
This applies to the comparison with the conventional bone conduction hearing 
aids and air conduction hearing aids as well as to the implementation of the BA-
HA HC220 with a larger output than the standard BAHA HC200 The HC220 
can be fitted in a small group of patients with a severe mixed hearing loss, 
sometimes involving patients who previously could not be rehabilitated 
adequately with a conventional bone conduction hearing aid 
In chapter 2 the clinical results of 68 percutaneous implants in 65 patients, 
placed in two surgical stages are presented After a follow-up period of 8 to 45 
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months 97% of the implants were still anchored in the temporal bone In 86% of 
the implants, no potentially dangerous skin reactions occurred The occurrence 
of skin reactions did not increase over time In chapter 3 the preliminary results 
are presented of 28 percutaneous implants implanted in 28 patients using a one 
stage instead of a two stage procedure A one stage procedure could contribute 
to a diminuation ol cost of the application of the BAH A system After a follow 
up period of 5 to 17 months 91% of implants were anchored in the temporal 
bone The results confirm results of the Goteborg group 
In chapter 4 the audiological results of the standard BAHA HC200 of a three 
centre study are presented Sixty-two patients with conductive or mixed hearing 
loss were fitted with this type of BAHA In the speech recognition-in-quiet test 
only 5 (10%>) of the 52 patients who previously used a conventional bone 
conduction hearing aid improved significantly the majority had 100% scores 
with both hearing aids In the speech recogmtion-in-noise test, 28 patients (54%>) 
of the 52 patients improved significantly In 6 of the 10 patients who previously 
used an air conduction hearing aid the speech recognition-in-noise improved 
significantly From the whole group of 62 patients, the performance of only two 
patients (both used an air conduction hearing aid previously) was significantly 
worse with the BAHA on one of the speech recognition tests 
In chapter 5 the audiological results of the more powerfull BAHA HC220 are 
presented Twenty-six patients with severe mixed hearing loss were fitted with this 
"superbass" bone anchored hearing aid Speech recognition-in-quiet tests revealed 
no change in maximum phoneme score in 7 (37%) of the 19 patients who previously 
used a conventional bone conduction hearing aid and an improvement was 
obtained in the remaining 12 patients (63%i) Of the 7 patients who previously used 
an air conduction hearing aid, the maximum phoneme score improved in 3 patients, 
worsened in 3 patients and did not change in 1 patient Speech recognition-in-noise 
was difficult for most ot these patients However, results were obtained from 10 of 
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the 26 patients and 7 improved significantly and 3 showed no change with the 
HC220 compared to their previous aid Overall, speech recognition with the HC220 
was comparable with or better than with a conventional bone conduction hearing 
aid, however, compared with an air conduction hearing aid the results were 
ambiguous 
In chapter 6 the influence of the thickness of the skin and subcutaneous tissue 
covering the mastoid on transcutaneously versus percutaneously obtained bone 
conduction thresholds is discussed It is argued that the thicker the skin and 
subcutaneous tissue, the greater the improvement in bone conduction thresholds 
when stimulating percutaneously Percutaneous and transcutaneous bone 
conduction thresholds were obtained at 0 25, 0 5, 1,2 and 4 kHz in 57 patients 
who were fitted with the BAHA Additionally, the thickness of the skin and 
subcutaneous tissue covering the mastoid was determined No relationship was 
found between the thickness of the skin and subcutaneous tissue and the 
improvement in bone conduction thresholds at any of the frequencies Therefore, 
the thickness of the skin and subcutaneous tissue layers measured pre-operative-
ly cannot be used to predict whether the fitting of a BAHA will be successfull 
In chapter 7 the patients' opinions regarding the BAHA versus the previous 
conventional hearing aid are evaluated A questionnaire was completed prior to 
the surgical procedure with respect to the conventional hearing aid and again 5 
months later with respect to the BAHA Sixty-five consecutive patients partici-
pated of whom 49 patients had previously used a conventional bone conduction 
hearing aid and 16 patients an air conduction hearing aid Compared to the 
conventional bone conduction hearing aid, the patients favoured the BAHA on 
all hearing-aid-related aspects A significant improvement in speech recognition 
was found in quiet, noise, quality of sound and comfort The results with the 
BAHA compared with the air conduction hearing aid were ambiguous with 
respect to speech recognition All the patients who previously used an air 
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conduction hearing aid recognized the enormous benefit of a decrease or 
complete disappearance in ear infections Almost all patients used their BAHA 
for more than 8 hours per day 
The clinical results described in this thesis concerning the anchorage of the 
titanium implant in the temporal bone and the occurrence of skin reactions are 
in agreement with the results obtained in Goteborg The implantation of a 
percutaneous titanium implant in one stage is a fanly new procedure The results 
of the one stage procedure presented in this study concern short term results 
The percentage of implants successfully anchored in the temporal bone was high 
and the occurrence of skin reactions showed no significant difference compared 
to that of the two stage procedure As long term results of the one stage 
procedure in the temporal bone are not yet available it is advocated to use the 
two stage procedure in patients who are likely to have a higher risk of losing the 
implant, ι e patients who have had a radiotherapy treatment involving the 
temporal bone8 and possibly in patients who have already lost an implant once 
as a result of an infection or inadequate "osseointegration" The minimum age 
for implantation was maintained at 10 years at the University Hospital 
Nijmegen In the literature, a variety of success rates of osseointegrated titanium 
implants has been reported in children 9 1 0 
In most patients the percutaneous implant does not lead to any adverse skin 
reactions In the literature, relative movement of the skin surrounding the 
implant as in patients with a high skin or with a loose abutment, and with a 
pre-existing skin disease for example psoriasis, are reported to increase the 
occurrence of undesired skin reactions ' " p The importance of an extensive 
reduction of the subcutaneous tissue surrounding the implant and a pioper 
fixation of the abutment to the fixture was also emphasized in this study 
Because the BAHA system was only implemented in a patient when the fitting 
of a conventional hearing aid proved to be no longer possible, the higher risk 
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for a skin reaction in relation with the titanium implant in case of a pre-existent 
skin disease was accepted It can be concluded that the percutaneous titanium 
implant provides a stable connection between transducer and the temporal bone 
A meticulous surgical technique and a good patient selection are prerogatives for 
these results 
Il has been shown in this study that the patients performed better in the audio-
logical tests with the BAHA HC200 than with the conventional bone conduction 
hearing aid The improvement is related to the difference between the two hear-
ing aid systems, not to patient-related factors Because the present publications 
on the results with the more powerfull "superbass" BAHA HC220 all originated 
solely from the patient group described in this study, a comparison with other 
centres was not possible Besides the improvement in speech recognition with the 
BAHA HC220 compared to the conventional bone conduction hearing aid, it is 
important that with this hearing aid a specific patient group can be rehabilitated, 
it concerns the patient group with severe mixed hearing loss with such a large 
sensorineural hearing loss component that a conventional bone conduction 
hearing aid often proves to be inadequate In patients who had previously used 
an air conduction hearing aid, the audiological results with the BAHA were 
ambiguous but on average the patients performed equally well with either a 
BAHA HC200 or a BAHA HC220 compared to their previous hearing aid 
The results of the questionnaire were in agreement with the audiological results 
and confirm the favourable experiences with this new type of bone conduction 
hearing aid Patients with an average bone conduction threshold at 0 5, 1 and 2 
kHz of less than 65 dB HL can be adequately fitted with the BAHA with a 
likely objective and/or subjective improvement of speech recognition compared 
to the previous bone conductor In view of the results the BAHA is considered 
to be superior to the conventional bone conduction hearing aid However, in 
comparison to binaural hearing glasses some patients find directional hearing 
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less adequate with the BAHA and it may also be more difficult to understand 
someone speaking at the contralateral side of the head Further disadvantages of 
the BAHA are that at least one operation is needed, the percutaneous implant 
needs care and the cost of the surgical treatment and transducer greatly exceed 
that of the conventional bone conduction hearing aid A crash helmet cannot be 
worn together with the BAHA Therefore, it remains sensible to consider a trial 
with a conventional bone conduction hearing aid if an air conduction hearing 
aid cannot be used for any reason If this trial is unsuccessful and subsequently 
a BAHA is fitted, the possible deterioration in speech recognition compared to 
the previous air conduction hearing aid should be discussed with the patient In 
this respect, setting up meetings between potential candidates and BAHA-
patients can be a significant contribution to the selection procedure 
The BAHA is an important addition to the hearing aids at the disposal of an 
otologist or a clinical audiologist As it concerns a fairly new development, 
further assessment of factors that influence hearing with a BAHA may lead to 
further improvements of the system As it has been shown that the earlier 
favourable results with the BAHA system are reproducible, the same can be 
expected of the long term results In view of the potential of the BAHA system 
in the rehabilitation of a selected patient group, the budget for the implementa­
tion of the system should be increased nationally In addition to the gain in 
communicative possibilities of a group of patients, it may lead to a decrease in 
the utilisation of social security resources 
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In dit proefschrift worden de resultaten besproken van een prospectieve klinische 
studie naar de toepassing van een nieuw type beengeleidingshoortoestel Met het 
conventionele beengeleidingshoortoestel worden geluidstnllingen door middel 
van een stevig tegen het hoofd gedrukte transducer aan de schedel overgedragen 
Met het in dit proefschrift beschreven percutané systeem wordt de huid perma-
nent doorboord door een titanium implantaat Aan dit percutané implantaat 
kan een speciaal beengeleidingshoortoestel, genoemd de Bone Anchored Hearing 
Aid (ВАНА), gekoppeld worden De huid die door het implantaat doorboord 
wordt betreft een autoloog transplantaat, welke wordt gewonnen uit een haarvnj 
gebied en vervolgens sterk wordt gedund Ter plekke van de implantatie wordt 
het periosteum veiwijderd Het subcutane weefsel van het omringende gebied 
wordt gereduceerd, teneinde beweging van de huid ten opzichte van het implan­
taat te beperken 
Hoewel in Zweden een aantal histologische, audiologische en klinische studies 
naar het ВАНА systeem zijn uitgevoerd,' 9 1 4 5 6 7 zijn additionele prospectieve 
studies uit andere centra wenselijk Het is van belang te weten of de goede 
resultaten, die behaald werden in Goteborg, ook elders gereproduceerd kunnen 
worden Een verbreding van de kennis, over de mate waarin het gehoor en het 
spraakverstaan verbeterd kunnen worden met de BAHA in standaardcondities, 
is noodzakelijk Dit geldt zowel voor de vergelijking met conventionele been-
geleidingshoortoestellen en luchtgeleidingshoortoestellen, als voor de toepassing 
van de BAHA HC220 die een grotere output dan de standaard ВАНА HC200 
heeft De BAHA HC220 kan worden aangepast bij een kleine groep patiënten 
met een ernstig gemengd gehoorverhes Bij enkele patiënten van de groep kon 
voorheen niet adequaat een conventioneel beengeleidingshoortoestel aangepast 
worden 
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In hoofdstuk 2 worden de klinische resultaten gepresenteerd van 68 percutané 
implantaten, die in twee chirurgische fasen zijn geplaatst bij 65 patiënten Als 
eerste werd de onderschroef geplaatst in het temporale bot en na een periode 
van 4 maanden werd de percutané bovenbouw geplaatst Na een follow-up 
periode variërend van 8 tot 45 maanden, bleek 97% van de implantaten 
verankerd in het temporale bot Bij 86% van de implantaten deed zich geen 
potentieel gevaarlijke huidreactie voor Het voorkomen van huidreacties bleek 
niet tijdsafhankelijk 
In hoofdstuk 3 worden de voorlopige resultaten beschreven van de implantatie 
van 28 percutané implantaten bij 28 patiënten, geplaatst in een chirurgische fase 
Een dergelijke chirurgische procedure zou kunnen bijdragen aan een verminder-
ing van de kosten van het aanpassen van het BAHA systeem Na een follow-up 
periode, variërend van 5 tot 17 maanden, bleek 93% van de implantaten 
verankerd in het temporale bot Deze bevindingen bevestigen de resultaten van 
de Goteborg-groep 
De audiologische resultaten met de standaard BAHA HC200, verkregen uit een 
multicenter studie, worden besproken in hoofdstuk 4 Beschreven worden 62 
patiënten met een conductief of gemengd gehoorverhes waarbij dit type BAHA 
werd aangepast Slechts 5 (10%) van de 52 patiënten die voorheen een conven-
tioneel beengeleidingshoortoestel droegen behaalden een significant beter 
resultaat in de spraakverstaan-in-stilte test de meerderheid van de patiënten 
behaalde 100% scores met beide hoortoestellen In de spraakverstaan-in-ruis test 
behaalden 28 (54%) van de 52 patiënten een significant beter resultaat met de 
BAHA Zes van de 10 patiënten die voorheen een luchtgeleidingshoortoestel 
droegen, behaalden een significant beter resultaat in de spraakverstaan-in-ruis 
test Over de gehele groep genomen behaalden slechts 2 patiënten een significant 
slechter resultaat bij een van de spraakverstaan tests Beide patiënten droegen 
voorheen een luchtgeleidingshoortoestel 
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In hoofdstuk 5 worden de dudiologische resultaten besproken met de krachtigere 
BAHA HC220 BIJ 26 patiënten met een ernstig gemengd gehoorverlies werd 
deze "superbass" BAHA aangepast Van de 19 patiënten die voorheen een 
conventioneel beengeleidingshoortoestel droegen behaalden 12 (63%) patiënten 
een beter resultaat in de spraakverstaan-in-stilte test en bleef voor 7 patiënten de 
prestatie gelijk Van de 7 patiënten die voorheen een luchtgeleidingshoortoestel 
droegen, behaalden 3 patiënten een beter resultaat in diezelfde test, 3 patiënten 
behaalden een slechter resultaat, en bleef de prestatie van 1 patient gelijk met de 
BAHA De spraakverstaan-in-ruis test was moeilijk voor de meesten van deze 
patiëntengroep Desondanks werden bij 10 van de 26 patiënten resultaten 
verkregen Zeven van hen behaalden een significant beter resultaat met de 
BAHA ten opzichte van het vorige hoortoestel en 3 patiënten presteerden gelijk 
met de BAHA HC220 Het spraakverstaan met de HC220 werd verbeterd, of 
bleef vergelijkbaar met het conventionele beengeleidingshoortoestel Ten opzichte 
van het luchtgeleidingshoortoestel zijn de resultaten niet eenduidig 
In hoofdstuk 6 wordt nader ingegaan op de invloed van de dikte van de huid ter 
hoogte van het mastoid, op transcutaan versus percutaan verkregen been-
geleidingsdrempels Bij 57 patiënten waarbij een BAHA werd aangepast, werden 
transcutane en percutané beengeleidingsdrempels bepaald bij 0 25, 0 5, 1, 2, en 4 
kHz Tevens werd de dikte van de huid en subcutaan weefsel 1er hoogte van het 
mastoid bepaald Bij geen van de frequenties werd een relatie gevonden tussen 
de dikte van de huid en subcutaan weefsel en de verbetering van de been-
geleidingsdrempels, oftewel de percutaan minus de transcutaan verkregen been-
geleid ingsdrempels De pre-operatief gemeten dikte van de huid en subcutaan 
weefsel kan niet dienen als een indicator voor een succesvolle aanpassing van een 
BAHA 
In hoofdstuk 7 wordt de mening van de patient ten aanzien van de BAHA 
versus het voorheen gedragen conventionele hoortoestel geëvalueerd Voor de 
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chirurgische ingreep werd een enquête ingevuld betreffende het conventionele 
hoortoestel, vijf maanden na de operatie opnieuw betreffende de BAHA Vijf-en-
zestig patiënten participeerden, waarvan 49 patiënten voorheen een convention-
eel beengeleidingshoortoestel droegen en 16 patiënten een luchtgeleidingshoor-
toestel Wat betreft een aantal aan hoortoestellen gerelateerde aspecten, verkozen 
de patiënten de BAHA boven het conventionele beengeleidingstoestel Er werd 
een significante verbetering in spraakverstaan-in-stilte, spraakverstaan-in-ruis, 
kwaliteit van het geluid en comfort ervaren In de groep patiënten die voorheen 
een luchtgeleidingshoortoestel droeg, werd met betrekking tot het spraakverstaan 
geen eenduidig resultaat gevonden Het afnemen of zelfs geheel verdwijnen van 
de oorontstekingen, werd door alle patiënten als een zeer belangrijk voordeel 
aangemerkt Vrijwel alle patiënten droegen de BAHA meer dan 8 uur per dag 
De klinische resultaten met betrekking tot de verankering van het titanium 
implantaat in het temporale bot en het voorkomen van huidreacties, beschreven 
in dit proefschrift, komen overeen met de resultaten verkregen in Goteborg De 
implantatie van een percutaan titanium implantaat in een chirurgische procedure 
is nog redelijk nieuw en de hier vermelde resultaten betreffen dan ook korte 
termijn-resultaten Er werd een hoog percentage verankerde implantaten gevon-
den, waarbij het voorkomen van huidreacties statistisch niet significant 
verschilde van de twee fasen procedure Aangezien lange termijn resultaten nog 
niet voorradig zijn, lijkt het raadzaam om de twee fasen procedure toe te passen 
bij patiënten met een verhoogd risico tot verlies van het implantaat Te denken 
valt aan patiënten die een radiotherapeutische behandeling hebben ondergaan in 
het implantaliegebied,8 en mogelijk aan patiënten die reeds een implantaat 
hebben verloren als gevolg van een ernstige ontsteking of een onvolledige "osseo-
ïntegratie" In het Academisch Ziekenhuis Nijmegen werd vanaf het begin een 
minimum leeftijd van 10 jaar aangehouden voor de implantatie In de literatuur 
werden nadien wisselende percentages vermeld van succesvol verankerde 
implantaten bij kinderen 9 'ü 
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Bij de meeste patiënten gaf het percutané implantaat geen opmerkelijke 
huidreacties In de literatuur wordt vermeld dat (relatieve) beweging van de huid 
rond het implantaat, zoals bij patiënten met een hoge omringende huid of met 
een loszittende bovenbouw, en een pre-existerende huidziekte (zoals psoriasis), 
leiden tot meer ongewenste huidreacties 3 " p Het belang van een degelijke 
reductie van het subcutaan weefsel rondom het implantaat en een goede fixatie 
van de bovenbouw o( de onderschroef werd ook in dit proefschrift besproken 
Aangezien een BAHA slechts bij die patiënten werd aangepast die geen ander 
hoortoestel meer dragen konden werd een hoger risico op een huidreactie in 
geval van een preexisterende huidziekte aanvaard Geconcludeerd kan worden 
dal hel percutané titanium implantaat een stabiele verbinding vormt tussen de 
transducer en het temporale bot Een zorgvuldige chirurgische techniek en een 
goede palientenseleclie zijn voorwaarden voor dit resultaat 
In deze studie werd aangetoond dat de patiëntengroep in de audiologische tests 
betere resultaten behaalden met de BAHA HC200 dan met het conventionele been-
geleidingshoortoestel De verbetering is gerelateerd aan het verschil tussen de twee 
systemen, niet aan de aan patiënt-gerelateerde factoren Een vergelijking van de 
gegevens over de BAHA HC220 met andere centra is niet mogelijk, daar al de 
gepubliceerde resultaten met de krachtigere "superbass" BAHA HC220 verkregen 
zijn uit de in dit proefschrift beschreven patiëntengroep Naast de verbetering in het 
spraakverstaan met de BAHA HC220 ten opzichte van het conventionele been-
geleidingshoortoestel, is het belangrijk dat met dit hoortoestel een specifieke 
patiëntengroep gerehabiliteerd kan worden Het betreft hier die patiënten met een 
ernstig gemengd gehoorverhes met een dusdanig grote perceptieve component, 
waarbij een conventioneel beengeleidingshoortoestel vaak inadequaat blijkt te zijn 
De patiënten die voorheen een luchtgeleidingshoortoestel droegen behalen geen 
eenduidige resultaten met de BAHA, maar presteren gemiddeld met de BAHA 
HC200 (dan wel de BAHA HC220) op een zelfde niveau als met het vorige 
hoortoestel 
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De resultaten van de enquête kwamen overeen met de audiologische bevindingen 
en bevestigen de gunstige ervaringen met dit nieuwe type beengeleidingshoortoes-
tel Een indicator voor een adequate rehabilitatie met een BAHA in audio-
logische en/of in subjectieve zin, met een waarschijnlijke verbetering in het 
spraakverstaan ten opzichte van het conventionele beengeleidingshoortoestel, is 
een gemiddelde beengeleidings-drempel bij 0 5, 1 en 2 kHz van minder dan 65 
dB HL Gezien de resultaten wordt de BAHA, vergeleken met het conventionele 
beengeleidingshoortoestel, als superieur beschouwd Echter, sommige patiënten 
vinden het richting-horen met een BAHA minder adequaat dan met een 
binaurale hoorbnl, mogelijk is het spraakverstaan moeilijker aan de 
contralaterale zijde van het hoold Verdere nadelen zijn de noodzaak van 
tenminste een operatie, de zorg die het percutané implantaat behoeft, het feit dat 
de kosten van de chirurgische ingreep en de transducer die van een 
conventioneel hoortoestel ruimschoots overtreffen Een motorhelm kan boven-
dien niet samen met het hoortoestel gedragen worden Gezien het bovenstaande 
blijft het raadzaam een proefperiode met een conventioneel beengeleidingshoor-
loestel aan te gaan, als een luchtgeleidingshoortoestel niet gedragen mag worden 
Mocht een dergelijke proefperiode mislukken en een BAHA aangepast worden, 
dan is het noodzakelijk met de patient te bespreken dat een achteruitgang van 
het spraakverstaan ten opzichte van het luchtgeleidingshoortoestel mogelijk is In 
dit licht vormt het organiseren van een samenkomst van potentiële kandidaten 
en patiënten die reeds een BAHA dragen, een aanwinst voor de selectieproce-
dure 
De BAHA vormt een belangrijke aanvulling van het pakket hoortoestellen dat 
tot beschikking staat van otoloog en klinisch audioloog Verdere evaluatie van 
factoren die het horen met een BAHA beïnvloeden kunnen leiden tot een 
verdere verbetering van deze vrij nieuwe ontwikkeling Aangezien het is 
aangetoond dat de eerdere gunstige resultaten met het BAHA systeem 
reproduceerbaar zijn, kan hetzelfde verwacht worden van de lange termijn 
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resultaten In het licht van de potentie van het BAHA systeem in de rehabilitatie 
van een geselecteerde groep patiënten, zou op nationaal niveau een budget voor 
de toepassing van het systeem beschikbaar moeten zijn In aanvulling op de 
winst in communicatieve mogelijkheden van een groep patiënten, leidt dit 
systeem mogelijk tot een verminderd gebruik van gemeenschapsgelden 
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Appendix I 
The volume setting of the body-level hearing aid for the 8 patients who used the 
same body-level hearing aid combined with the previous conventional bone 
conduction transducer and the HC220 was on average 1.7 points lower when 
using the HC220. To express this in output measures, the following set-up was 
chosen: as no standard measuring equipment to measure the performance of a 
bone anchored hearing aid is available, the output of the body-level amplifier 
was measured not with the bone conduction transducers but using the standard 
earphone recommended by the manufacturer on a 2cc coupler (CAS, Danavox). 
The average gain at 500, 1000 and 2000 Hz, the second harmonic distortion and 
the input-output function at 800 Hz were determined. These three measures were 
determined twice, once at the volume setting used by the patients when wearing 
the conventional transducer and once at the volume setting used when wearing 
the HC220. On average, at the volume setting used with the HC220, the average 
gain was 6 dB less, the distortion 6% less (5% versus 11%) and the input level at 
which the amplifier saturated was 5 dB higher (76 versus 71 dB SPL). Therefore, 
the reduced volume setting when applying the HC220 leads to better 
performance from the hearing aid amplifier. 
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Questionnaire A 
(1) How many hours per day did you use your previous hearing aid (CHA)? 
> 8 hours Π 4 - 8 hours • 2 - 4 hours Π < 2 hours • not at all • 
How many hours per day do you use your BAHA? 
> 8 hours U 4 - 8 hours Π 2 - 4 hours Π < 2 hours Π not at all Π 
(2) Which hearing aid is better with regard to 
-A: 
- B: 
- C : 
- D: 
- E: 
- F: 
ear infections 
speech recognition 
sound quality 
visability 
skin irritation 
handling 
CHA 
CHA 
CHA 
CHA 
CHA 
CHA 
• 
• 
• 
Π 
π 
π 
ВАНА 
ВАНА 
ВАНА 
ВАНА 
ВАНА 
ВАНА 
D 
D 
• 
• 
• 
Π 
no difference 
по difference 
по difference 
по difference 
по difference 
по difference 
Π 
• 
Π 
D 
• 
• 
(3) On which of these hearing-aid-related apects A to F does the BAHA 
distinguish itself most from the previous hearing aid in a positive sense? 
greatest advantage, aspect ..., 2nd most important advantage, aspect ... 
(4) On which of these hearing-aid-related aspects A to F does the BAHA 
distinguish itself most from the previous hearing aid in a negative sense? 
greatest disadvantage, 2nd most important disadvantage, 
aspect... aspect... 
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(5) How good is your speech recognition in situations with background noise 
(party or group gathering) with the BAHA compared to your previous 
hearing aid9 
much better • better Π equal • worse Π much worse Π 
Questionnaire В 
(1) (Speech recognition in quiet) 
When it is quiet, can you understand 
a one man
7
 b one woman9 с one child9 d television9 
e radio9 
(2) (Speech recognition in noise) 
Can you understand someone who is speaking 
a while the radio or television is on 9 b at a party or meeting9 
с in a crouded hall9 d in a restaurant9 e in a street with a lot of traffic9 
f in a busy shop9 g in a lecture hall9 h on a bus or train9 
ι in a car9 
(3) (Quality of sound) 
What is your opinion on the quality of sound of 
a the voices of men9 b the voices of women9 с the voices of children9 
d your own voice9 e music9 f a telephone conversation9 g cutlery9 
h drilling9 ι slamming doors9 j passing trains9 к traffic9 
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(4) (Wearing comfort): 
a. Is your hearing aid comfortable to wear? b. Is your hearing aid 
practical in everyday use? с Are you troubled by rustling noises when 
moving around? d. How do you view the hearing aid with regard to feed­
back? e. Do you experience troublesome intrinsic noise from your hearing 
aid? 
Two questions were posed after the patient had been fitted with the BAHA: 
Do you experience difficulty with cleaning the skin around the abutment? 
yes D sometimes Π no • 
And for the patients who had previously used a conventional hearing aid 
binaurally: which hearing aid is better with regard to directional hearing? 
CHA • ВАНА • no difference Π 
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Distribution of patients rehabilitated with the Bone Anchored Hearing Aid at 
three centres in The Netherlands. 
155 
156 
A C K N O W L E D G E M E N T 
Had it not been for my promotor Prof dr Paul van den Broek, by whom I was 
introduced to the initiators of this research project, my co-promotors Dr Cor 
W R J Cremers and Dr Ir Ad F M Snik, I would not have been in the position to 
write this thesis m the first place It has given me a good opportunity to 
comprehend some of the techniques and ethics of research and to appreciate the 
value of it for our profession The support and advice given and the effort made by 
my co-promotors to achieve this result is commemorable The fourth pillar of our 
BAHA team, Andy J Beynon gathered numerous audiological data, providing a 
part of the basis of the audiological research On behalf of the BAHA team I want 
to thank Drs Nico W van den Berge from the Diaconessenhuis in Eindhoven, Ir 
Frank F Jorntsma of the Audiological Centre Eindhoven, Dr Paul Wildervanck 
de Blecourt and Dr Hans Verschuure of the University Hospital in Rotterdam for 
their interest and cooperation in the multicentre study of the results with the 
BAHA In addition to the value it has added to this thesis, it has resulted in a more 
uniform approach of several aspects of this hearing aid system in The Netherlands 
Furthermore, I want to thank Dr Patrick L M Huygen from the University 
Hospital Nijmegen for the statistical review of chapter 2, and Dr Per Carlson and 
Dr Bo Hâkansson from Goteborg for their review of chapter 6 I am particularly 
gratefull to Mr David W Proops, consultant ENT surgeon the Queen Elizabeth 
Hospital in Birmingham, who has given me the opportunity to participate in his 
"osseointegration team" as a Senior House Officer, and Mr Adrian Drake-Lee, 
consultant ENT surgeon at the same institute, for the review of parts of the thesis 
Norbert Croonenberg is responsible for the design of the cover of this thesis on 
which he has, again, done an excellent job Ms Marlou Ackermans-de Leeuw has 
made the accurate drawings of chapter 3, and Mr Jan Meeuwissen provided skill in 
photography This manuscript was completed thanks to hours and hours of 
157 
secretarial and mental support by Ms Diny Helsper and Ms Lisette Sanders 
Sylvia, I thank you for the moments of patience, support and for tearing me away 
from the PC once in a while to enjoy life 
158 
C U R R I C U L U M VITAE 
De auteur van dit proefschrift werd op 15 februari 1962 geboren te Nijmegen en 
behaalde na middelbaar onderwijs te hebben genoten aan het Eckart College te 
Eindhoven en aan het St Maartenscollege te Maastricht het diploma VWO В in 
1981 Nadat aan de Universiteit van Amsterdam het piopadeuse Biologie werd 
behaald, werd aangevangen met de studie Geneeskunde aan de Katholieke 
Universiteit Nijmegen Na de medische studie werd als onderzoeks-assistent 
binnen de afdeling Keel-, Neus- en Oorheelkunde van het Academisch 
Ziekenhuis Nijmegen (1991 - 1993) de basis voor dit proefschrift gelegd Na 
enige tijd werkzaam te zijn geweest in Birmingham, Engeland, is sinds 1 mei 
1994 E A M Mylanus arts-assistent in opleiding tot Keel-, Neus- en Oorarts in 
het Academisch Ziekenhuis Nijmegen 
159 

STELLINGEN 
1 Een volgens de methode van Brânemark in het temporale bot geplaatste 
percutané titanium schroef vormt een stabiele verbinding met een hoog en 
reproduceerbaar verankenngspercentage 
2 Het plaatsen van percutané titanium implantaten in het temporale bot 
dient bij voorkeur in een zitting plaats te vinden 
3 Uit de resultaten van de spraakverstaantests blijkt dat de meerderheid van 
de patiënten met een BAHA beter presteert dan met een conventioneel 
beengeleidingshoortoestel 
4 De dikte van de huid en het subcutane weefsel ter plaatse van het te 
plaatsen percutané titanium implantaat heeft geen voorspellende waarde 
voor het resultaat van een BAHA ten opzichte van een conventioneel 
beengeleidingshoortoestel 
5 Als gevolg van het vastlopen van de versterker bij een bepaalde volume-
instelling van zowel het conventionele beengeleidingshoortoestel als de 
BAHA wordt de bij hoortoestelaanpassing vaak nagestreefde compensatie 
van de helft van het perceptieve gehoorverhes zelden gehaald 
6 Het verwijderen van tympanosclerotische plaques uit het trommelvlies bij 
het verrichten van een mynngoplastiek heeft geen invloed op het succes-
percentage 
(EWJ Wiehnga et al Am J Otol ¡994) 
7 De resultaten van CT-scanning van de ossa petrosa en van uitgebreide 
audiometrie bij patiënten met het geslachtsgebonden recessief overervende 
syndroom met als kenmerken een progressief gemengd gehoorverlies en 
een perilymphe gusher bij stapes chirurgie (McK 304400) wijzen in de 
richting van een zuiver perceptief gehoorverlies en niet op een gemengd 
gehoorverlies 
8 Een voordeel van het gebruik van keramische prothesen ten opzichte van 
allologe implantaten bij reconstructie tussen een mobiele voetplaat 
enerzijds en het trommelvlies met hamersteel anderzijds is dat de lengte 
van de prothese duurzaam op maat gemaakt kan worden 
9 Het voorkomen van non-penetrantie bij het Treacher Collins syndroom is 
inmiddels afdoende bewezen 
(HAM Manes thesis 1994) 
10 Concentratie van de operatieve behandeling van zeldzame aandoeningen 
leidt zonder hogere behandehngskosten tot een beter resultaat Het is 
daarom nodig dat dergelijke concentraties van overheidswege veel sterker 
beleidsmatig worden ondersteund 
11 De grenzen van de wetenschap worden verlegd door wilskracht en 
inspanning, worden vastgesteld door erkenning, worden vanzelfsprekend 
door gewenning, om vervolgens weer te kunnen vervagen door schijnbare 
waanzinnigheid 
12 Ook de patient by wie een schroefje los zit behoeft een serieuze 
benadering 
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